Book Chapters

  • “The growing influence of nanotechnology in our lives”, A. Ranzoni and M.A. Cooper, in “Micro and nanotechnology for vaccine development”, Eds. M Skwarczynski and I Toth, 2016, William Andrew, ISBN: 9780323400299
  • "Label-free technologies - Which technique to use and what to watch out for ” in " Label-free Biosensor Methods in Drug Discovery." Ed. Y. Fang, Springer Methods in Pharmacology & Toxicology Series 2015, ISBN: 978-1-4939-2616-9.

  • Sensor surfaces and receptor deposition” in "Label-free Biosensors: Techniques and Applications" Ed. M.A. Cooper, Cambridge University Press, 2009,
    ISBN-13: 9780521711517.

  • Interactions with membranes and membrane receptors” in "Label-free Biosensors: Techniques and Applications" Ed. M.A. Cooper, Cambridge University Press, 2009,
    ISBN-13: 9780521711517.

  • Resonant Acoustic Profiling and Rupture Event Scanning” in "Piezoelectric Sensors", Vol. 5, 2006, Springer Verlag, Eds. Steinem C., Janshoff A., (part of the book series “Chemical Sensor and Biosensors, Series Ed. Otto S. Wolfbeis).


Journal Articles


  1. Elucidating the lipid binding properties of membrane active peptides using cyclised nanodiscs, I.H.. Zhang, I.A. Edwards, B.P. Mishra, G. Sharma, M.D. Healy, A.G. Elliot, M.A. Blaskovic, M.A. Cooper, B.M. Collins, X Jia and M. Mobli, Frontiers in Chemistry. 2019 10.3389/fchem.2019.00238
  2. Antimicrobial anilinium polymers: The properties of poly(N,N‐dimethylaminophenylene methacrylamide) in solution and as coatings, A Chen, J Tang , MA Cooper, J Perera, S Swift, AK Whittaker, Polymer Chemistry, 2019, 10.1002/pola.29314

top of page



  1. Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays, A Kavanagh, S Ramu, Y Gong, MA Cooper, MA Blaskovich, American Society of Microbiology, 2018, 10.1128/AAC.01760-1
  2. Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria. T Velkor, A Gallardo, M Han, MA Cooper, et al. Cell Chemical Biology, 2018, 25(4):380-91.e5. 10.1016/j.chembiol.2018.01.005.
  3. Design, synthesis and biological evaluation of 2-nitroimidazopyrazin-one/-es with antitubercular and antiparasitic activity, A Jarrad, K Nicholas, M Blaskovich, M.A Cooper, et al. Medicinal Chemistry Manuscript, 2018, 10.1021/acs.jmedchem.8b01578
  4. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice, R Gordon, E Albornoz, D Christie, M Langley, MA Cooper, TM Woodruff, et al. Science Trans. Med, 2018, 10.1126/scitranslmed.aah4066
  5. Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance. MRL Stone, MS Butler, W Phetsang, MA Cooper, MAT Blaskovich. Trends in Biotechnology, 2018, 36(5):523-36. 10.1016/j.tibtech.2018.01.004
  6. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. S Sano, K Oshima, Katanasaka Y, Sano M, Cooper MA, et al. J. Am. College of Cardiology, 2018, 71(8):875-86. 10.1016/j.jacc.2017.12.037
  7. Synthesis of deuterium-labelled analogues of NLRP3 inflammasome inhibitor MCC950. Salla M, Butler MS, Massey NL, Reid JC, Cooper MA, Robertson AAB. Bioorganic & Medicinal Chemistry Letters, 2018, 28(4):793-5. 10.1016/j.bmcl.2017.12.054
  8. Canakinumab for atherosclerotic disease. Rothman AM, Morton A, Crossman D, O'Neill, L, Cooper MA. The New England J. Medicine, 2018,10.1128/AAC.00986-17
  9. The Eagle Effect and Antibiotic-Induced Persistence: Two Sides of the Same Coin? Prasetyoputri A, Jarrad AM, Cooper MA, Blaskovich MAT. Trends in Microbiology. 2018, 10.1016/j.tim.2018.10.007
  10. Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Pitt ME, Elliott AG, Cao MD, Ganesamoorthy D, Karaiskos I, Giamarellou H, Cooper MA, et al. Microbial genomics, 2018, 4(3):e000158. 10.1099/mgen.0.000158
  11. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate. Pitt ME, Cao MD, Butler MS, Ramu S, Ganesamoorthy D, Blaskovich, Cooper MA, MAT, et al. J. Antimicrobial Chemotherapy, 2018, 10.1093/jac/dky458
  12. Otapeptin C4 Induces Less Resistance and Novel Mutations in an Epidemic Carbapenemase-producing Klebsiella pneumoniae ST258 Clinical Isolate Compared to Polymyxins, M Pitt, M Duc Cao, M Butler, S Ramu, D Ganesamoorthy, M Blaskovich, L Coin, M Cooper. Cold Spring Harbor Laboratory, 2018, 10.1101/309674
  13. A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase. Paparella AS, Feng J, Blanco-Rodriguez B, Feng Z, Phetsang W, Cooper MA, Blaskovich MAT, et al. Tetrahedron, 2018, 74(12):1175-83. 10.1016/j.tet.2017.10.032.
  14. Silver bullets: A new lustre on an old antimicrobial agent. Möhler JS, Sim W, Blaskovich MAT, Cooper MA, Ziora ZM. Bio Advances, 2018, 36(5):1391-411. 10.1016/j.biotechadv.2018.05.004.
  15. A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome. Mathur A, Feng S, Hayward JA, Ngo C, Fox D, Atmosukarto II, Cooper MA et al. Nature Microbiology, 2018, 10.1038/s41564-018-0318-0
  16. The Small Molecule NLRP3 Inflammasome Inhibitor MCC950 Does Not Alter Wound Healing in Obese Mice. Lee J, Robertson A, Cooper M, Khosrotehrani K. J. Molecular Sciences, 2018, 10.3390/ijms19113289
  17. Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles. Kummari LK, Butler MS, Furlong E, Blundell R, Nouwens A, Matthew A Cooper, Silva AB, et al. Bioorganic & Medicinal Chemistry, 2018, 26(20):5408-19. 10.1016/j.bmc.2018.09.004
  18. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage and dysfunction in salt-sensitive hypertension. Krishnan SM, Ling YH, Huuskes BM, Ferens D, Matthew A Cooper, Saini N, Chan CT, et al. Cardiovascular Research, 2018, 10.1093/cvr/cvy252
  19. Pharmacological inhibition of the NLRP3 inflammasome prevents α-synuclein pathology and dopaminergic degeneration, Ri Gordon, E.A. Albornoz, D.C. Christie, M Langley, V Kumar, S Manotovani, M Butler, D Rowe, L.A. O’Neill, Kate Schroder, M.A. Cooper, T.M. Woodruff, et al. Science Translational Medicine, 2018, 2018, 10 (465), eaah4066
  20. Antifungal Benzo [b]thiophene 1,1-dioxide IMPDH Inhibitors Exhibit Pan-Assay Interference (PAINS) Profiles, L.K. Kummariab, M.S. Butler, Alberto B. Silvace, James A. Fraser, Matthew A.Cooper, Avril A.B.Robertson, et al. Bioorganic & Medicinal Chemistry, 2018, 26(20):5408-5419. 10.1016/j.bmc.2018.09.004
  21. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain. Khan N, Kuo A, Brockman DA, Cooper MA, Smith MT. Science Translational Medicine, 2018, 26(1):77-86. 10.1007/s10787-017-0401-9
  22. Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays. Kavanagh A, Ramu S, Gong Y, Cooper MA, Blaskovich MAT. Antimicrobial Agents and Chemotherapy. Antimicrobial agents and chemotherapy, 2018, 10.1128/AAC.01760-18
  23. Evidence against a role for NLRP3-driven islet inflammation in db/db mice. Kammoun HL, Allen TL, Henstridge DC, Barre S, Coll RC, Lancaster GI, M. A. Cooper and M. A. Febbraio et al. Molecular Metabolism, 2018, 10.1016/j.molmet.2018.02.001
  24. Cell‐free production of a therapeutic protein: Expression, purification, and characterization of recombinant streptokinase using a CHO lysate. K Tran, M Tolosa, A Zuber, C Peñalber‐Johnstone, C Dinkins, N Pezeshk, Y Kostov, D Frey, L Tolosa, DW Wood, G Rao. Biotechnology and bioengineering, 2018, 10.1002/bit.26439
  25. Detection and Investigation of Eagle Effect Resistance to Vancomycin in Clostridium difficile With an ATP-Bioluminescence Assay. J AM, Blaskovich MAT, Prasetyoputri A, Karoli T, Hansford KA, Cooper MA. Frontiers in microbiology, 2018, 9:1420-. 10.3389/fmicb.2018.01420
  26. Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity. Jarrad AM, Ang CW, Debnath A, Hahn HJ, Woods K, Tan L, Cooper MA et al. J. Medicinal Chemistry, 2018, 10.1021/acs.jmedchem.8b01578
  27. Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane. Hickey SM, Ashton TD, Boer G, Bader CA, Thomas M, M.A. Cooper, Elliott AG, et al. European J. Medicinal Chemistry, 2018, 10.1016/j.ejmech.2018.09.072
  28. A nanoparticle-based method for culture-free bacterial DNA enrichment from whole blood. Hassan MM, Ranzoni A, Cooper MA. Biosensors and Bioelectronics, 2018, 99:150-5. 10.1016/j.bios.2017.07.057
  29. Detection and quantification of the heterogeneity of S. aureus bacterial populations to identify antibiotic-induced persistence. Hassan MH, Butler MS, Ranzoni A, Cooper MA. Cold Spring Harbor Laboratory, 2018, 10.1101/320093
  30. An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4 and AIM2 inflammasomes. J.L. Chitty, M.S. Butler, Azzah Suboh, D.J. Edwards, M.A. Cooper, J.A. Fraser and Avril A. B. Robertson, Antimicrobial Agents and Chemotherapy, 2018, 10.1128/AAC.00986-17
  31. Exploiting Macromolecular Design To Optimize the Antibacterial Activity of Alkylated Cationic Oligomers. Grace JL, Schneider-Futschik EK, Elliott AG, Amado M, Truong NP, Cooper MA, et al. Biomacromolecules, 2018, 10.1021/acs.biomac.8b01317
  32. Antimicrobial octapeptin C4 analogues active against Cryptococcus species,Jessica L Chitty, Mark S Butler, Azzah Suboh, David J Edwards, Matthew A Cooper, James A Fraser, Avril AB Robertson. Antimicrobial agents and chemotherapy, 2018, 10.1128/AAC.00986-17
  33. Structural and functional characterization of a cross-reactive dengue virus neutralizing antibody that recognizes a cryptic epitope, J Li, D Watterson, SR. Fry, M.A Cooper, PR Young, B Kobe, Structure, 2018, 26(1), 51-59, 10.1016/j.str.2017.11.017
  34. Protein inspired antibiotics active against vancomycin and daptomycin resistant bacteria, M Blaskovich, Y Gong, K Hansford, M Butler, C Muldoon, A Beevers, R Smith , J Roberts, D Paterson, M Cooper, et al. Nature Communications, 2018, 10.1038/s41467-017-02123-w
  35. Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitis. Chen ACH, Tran HB, Xi Y, Yerkovich ST, Baines KJ, M Cooper, SJ Pizzutto, et al. ERJ Open Research, 2018, 10.1183/23120541.00130-201732
  36. CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury, R Chakraborty, J Chandra, S Cui, L Tolley, M Kendall, M Cooper, I Frazer, Experimental Dermatology, 2018, 10.1111/exd.13436
  37. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria? Blaskovich MAT, Pitt ME, Elliott AG, Cooper MA. Expert Review of Anti-infective Therapy, 2018, 16(6):485-99. 10.1080/14787210.2018.1483240
  38. Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Blaskovich MAT, Hansford KA, Gong Y, Butler MS, Muldoon C, Huang JX, Cooper MA, et al. Nature Communications, 2018, 9(1):22. 10.1038/s41467-017-02123-w
  39. Developments in Glycopeptide Antibiotics. Blaskovich MAT, Hansford KA, Butler MS, Jia Z, Mark AE, Cooper MA. ACS Infectious Diseases. 2018, 4(5):715-35. 10.1021/acsinfecdis.7b00258
  40. The NLRP3 Inflammasome Suppresses Protective Immunity to Gastrointestinal Helminth Infection. Alhallaf R, Agha Z, Miller CM, Robertson AAB, Sotillo J, Croese J, et al. Cell Reports, 2018, 10.1016/j.celrep.2018.03.097

top of page



  1. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. van Hout GPJ, Bosch L, Ellenbroek GHJM, de Haan JJ, van Solinge WW, Cooper MA, et al. European Heart Journal, 2017, 38(11):828-36. 10.1093/eurheartj/ehw247
  2. Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. T Henriques, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Cooper MA, Benfield AH, et al. ACS Chemical Biology, 2017, 12(9):2324-34. 10.1021/acschembio.7b00459
  3. Structure-activity and -toxicity relationships of the antimicrobial peptide tachyplesin-1, I Edwards, A Elliott, A Kavanagh, M Blaskovich, M Cooper, ACS Infectious Diseases, 2017, 3(12), 917-926, 10.1021/acsinfecdis.7b00123
  4. Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. Song E, Jahng JW, Chong LP, Sung HK, Matthew Cooper, Han M, Luo C, et al. American J. Translational Research, 2017, 9(6):2723-35.
  5. Plasma Protein Binding Structure–Activity Relationships Related to the N-Terminus of Daptomycin. Schneider EK, Huang JX, Carbone V, Han M, Zhu Y, MA Cooper, Nang S, et al. ACS Infectious Diseases, 2017, 3(3):249-58. 10.1021/acsinfecdis.7b00015
  6. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. Rose WE, Shukla SK, Berti AD, Hayney MS, Henriquez KM, Cooper MA, Ranzoni A, et al. Clinical Infectious Diseases, 2017, 64(10):1406-12. 10.1093/cid/cix157
  7. Inflammasomes in the lung, J W. Pinkerton, R Y. Kima, A A.B. Robertson, J A. Hirota, LG Wood, DA Knight, MA Cooper, L O’Neill, JC Horvat, P Hansbro, Molecular Immunology, 2017, 86, 44-55 10.1016/j.molimm.2017.01.014
  8. High fat diet-induced obesity promotes steroid-resistant asthma through an NLRP3 inflammasome-dependent mechanism, J Pinkerton, R Kim, J Mayall, MD Khadem Ali, M Starkey, A Robertson, L O'Neill, M Cooper, P Hansbro, J Horvat, Respirology, 2017, 22, 65-66
  9. PB1-F2 Peptide Derived from Avian Influenza A Virus H7N9 Induces Inflammation via Activation of the NLRP3 Inflammasome. Pinar A, Dowling JK, Bitto NJ, Robertson AA, Latz E, Matthew Cooper, Stewart CR, et al. J Biological Chemistry. 2017, 292(3):826-36. 10.1074/jbc.M116.756379
  10. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction. Pavillard LE, Cañadas-Lozano D, Alcocer-Gómez E, Marín-Aguilar F, Pereira S, Matthew A. Cooper, Robertson AAB, et al. Oncotarget, 2017, 8(59):99740-56. 10.18632/oncotarget.20763
  11. Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice. Overman J, Fontaine F, Moustaqil M, Mittal D, Sierecki E, Matthew A. Cooper, Sacilotto N, et al. eLIFE, 2017, 6:e21221, 10.7554/eLife.21221.001
  12. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. Neudecker V, Haneklaus M, Jensen O, Khailova L, Matthew A. Cooper, Masterson JC, Tye H, et al. Experimental Medicine, 2017, 214(6)1737-1752, 10.1084/jem.20160462
  13. Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action, JW Ndieyira, J Bailey, SB. Patil, M Vögtli, MA Cooper, Abell, RA McKendry, G Aeppli, Scientific Reports, 2017, 7, 41206.10.1038/srep41206
  14. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Cooper MA, Van Rooyen DM, et al. J. Hepatology, 2017, 66(5):1037-46. 10.1016/j.jhep.2017.01.022
  15. Enhancement of antibiotic-activity through complexation with metal ions - Combined ITC, NMR, enzymatic and biological studies. Möhler JS, Kolmar T, Cooper MA, Synnatschke K, Hergert M, Wilson LA, Ramu S, et al. J. Inorganic Biochemistry. 2017, 167:134-41. 10.1016/j.jinorgbio.2016.11.028
  16. Role for NLRP3 Inflammasome-mediated, IL-1beta-Dependent Responses in Severe, Steroid-Resistant Asthma. Kim RY, Pinkerton JW, Essilfie AT, Robertson AAB, Baines KJ, Cooper MA, Brown AC, et al. American J. Respiratory and Critical Care Medicine, 2017, 196(3):283-97. 10.1164/rccm.201609-1830OC
  17. Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors, JR. Hill, RC. Coll, N Sue, JC Reid, J Dou, CL. Holley, R Pelingon, JB. Dickinson, TJ. Biden, K Schroder, MA. Cooper, A Robertson, Chem Med Chem, 2017, 12(17), 1449-1457, 10.1002/cmdc.201700270
  18. Surface ligand density of antibiotic-nanoparticle conjugates enhances target avidity and membrane permeabilization of vancomycin-resistant bacteria, MM. Hassan, A Ranzoni, W Phetsang, M Blaskovich, MA. Cooper, Bioconjugate Chemistry, 2017, 28 (2), 353-361, 10.1021/acs.bioconjchem.6b00494
  19. Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes. Han M-L, Shen H-H, Hansford KA, Schneider EK, Sivanesan S, Matthew A. Cooper, Roberts KD, et al. ACS Infectious Diseases, 2017, 3(8):606-19. 10.1021/acsinfecdis.7b00065
  20. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative “Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. MH. Hussein, EK. Schneider, A G. Elliott, MA.T. Blastovich, M Mayo, M Baker, MA. Cooper, J Li, T Velkov et al. Mircobial Drug Resistance, 2017, 23(5):640-50. 10.1089/mdr.2016.0196
  21. Cationic acrylate oligomers comprising amino acid mimic moieties demonstrate improved antibacterial killing efficiency. Grace JL, Elliott AG, Huang JX, Schneider EK, Truong NP, Cooper MA, et al. J. Materials Chemistry, 2017, 5(3):531-6. 10.1039/C6TB02787C
  22. Antibacterial Nerol Cinnamates from the Australian Plant Eremophila longifolia, Savithri Galappathie, DJ. Edwards, AG. Elliott, MA. Cooper, EA. Palombo, MS. Butler, PJ. Mahon, Natural Products, 2017, 80, 4, 1178−1181, 10.1021/acs.jnatprod.6b00888
  23. “Tet2-mediated clonal hematopoiesis accelerates heart failure through an IL-1β/NLRP3 inflammasome mechanism,” Soichi Sano, Kosei Oshima, Ying Wang, Susan MacLauchlan, Yasufumi Katanasaka, Miho Sano, María A. Zuriaga, Minoru Yoshiyama, David Goukassian, Matthew A. Cooper, José J. Fuster and Kenneth Walsh, Journal of the American College of Cardiology, 2018, 71(8):875-886 , DOI:
  24. “Fluorescent Antibiotics: New Research Tools to Fight Antibiotic Resistance,” M. Rhia L. Stone, Mark S. Butler, Wanida Phetsang, Matthew A. Cooper and Mark A.T. Blaskovich, Trends in Biotechnology, Published online 22 February 2018, DOI:
  25. “Multifactorial Chromosomal Variants Regulate Polymyxin Resistance In Extensively Drug-Resistant Klebsiella pneumonia,” Miranda Pitt, Alysha Elliott, Minh Duc Cao, Devika Ganesamoorthy, Ilias Karaiskos, Helen Giamarellou, Cely S. Abboud, Mark A. T. Blaskovich, Matthew A. Cooper, and Lachlan Coin, Microbial Genomics, Published online 12 February 2018, DOI:10.1099/mgen.0.000158
  26. “Evidence against a role for NLRP3-driven islet inflammation in db/db mice,” H. L. Kammoun, T. L. Allen, D. C. Henstridge, S. Barre, R. C. Coll, G. I. Lancaster, L. Cron, S. Reibe, J. Y. Chan, M. Bensellam, D. R. Laybutt, M. S. Butler, A. A. B. Robertson, L. A. O’Neill, M. A. Cooper and M. A. Febbraio, Molecular Metabolism, Published online 7 February 2018, DOI:
  27. “New developments in glycopeptide antibiotics”, Mark Arnold Thomas Blaskovich, Karl A. Hansford, Mark Stuart Butler, ZhiGuang Jia, Alan Edward Mark, Matthew A. Cooper, ACS Infectious Diseases, Published online 24 January 2018, DOI: 10.1021/acsinfecdis.7b00258
  28. “Pharmacological inhibition of the NLRP3 inflammasome as a potential treatment for multiple sclerosis induced central neuropathic pain”, Nemat Khan, Andy Kuo, David A Brockman, Matthew A Cooper, Maree T Smith, Inflammopharmacology, 2018, 26(1), 77-86, DOI:
  29. “CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury”, Rituparna Chakraborty, Janin Chandra, Shuai Cui, Lynn Tolley, Mark Kendall, Matt Cooper, Ian Frazer, Experimental Dermatology, 2018, 27, 71-79, DOI: 10.1111/exd.13436
  30. “An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4 and AIM2 inflammasomes,” Lev Grinstein, Hella Luksch, Felix Schulze, Avril A.B. Robertson, Matthew A. Cooper, Angela Rösen-Wolff and Stefan Winkler, Clinical Immunology, Published online 26 2017, doi:
  31. “Canakinumab for Atherosclerotic Disease”, Luke A. O’Neill and Matthew A. Cooper, New England Journal of Medicine, 2018, 378:198-199, DOI:10.1056/NEJMc1714635
  32. “Antimicrobial octapeptin C4 analogues active against Cryptococcus species”, J. L. Chitty, M. S. Butler, Azzah Suboh, D. J. Edwards, M. A. Cooper, J. A. Fraser and Avril A. B. Robertson, Antimicrobial Agents and Chemotherapy, 2018, 62(2), e00986-17, DOI:10.1128/AAC.00986-17, doi:10.1128/AAC.00986-17
  33. “Structural and functional characterization of a cross-reactive dengue virus neutralizing antibody that recognizes a cryptic epitope,” Jie Li, Daniel Watterson, Chiung-Wen Chang, Xiao-Yan Che, Xiao-Quan Li, Daniel J. Ericsson, Li-Wen Qiu, Jian-Piao Cai, Jing Chen, Scott R. Fry, Stacey T.M. Cheung, Matthew A. Cooper, Paul R.Young and Bostjan Kobe, Structure, 2018, 26(1), 51-59, doi:
  34. “Protein inspired antibiotics active against vancomycin and daptomycin resistant bacteria”, Mark A.T. Blaskovich, Yujing Gong, Karl A. Hansford, Mark S. Butler, Craig Muldoon, Johnny X. Huang, Soumya Ramu, Alberto B. Silva, Mu Cheng, Angela M. Kavanagh, Zyta Ziora, Rajaratnam Premraj, Fredrik Lindahl, Tanya A. Bradford, June C. Lee, Tomislav Karoli, Ruby Pelingon, David J. Edwards, Noor Huda Daud, Johan E. Deecke, Hanna E. Sidjabat, Sefetogi Ramaologa, Johannes Zuegg, Jason R. Betley , Andrew P.G. Beevers, Richard A.G. Smith , Jason A. Roberts, David L. Paterson, Matthew A. Cooper; Nature Communications, 2018, 9:22, doi:10.1038/s41467-017-02123-w
  35. “Structure, function and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant Gram-negative bacteria”, Tony Velkov, Alejandra Gallardo-Godoy, James D. Swarbrick, Mark. A. T. Blaskovich, Alysha G. Elliott, Meling Han, Philip E. Thompson, Kade D. Roberts, Johnny X. Huang, Bernd Becker, Mark S. Butler, Lawrence H. Lash, , Sónia Troeira Henriques, Roger L. Nation, Sivashangarie Sivanesan, Marc-Antoine Sani, Frances Separovic, Haydyn Mertens, Dieter Bulach, Torsten Seemann, Jeremy Owen, Jian Li, Matthew A. Cooper, Cell Chemical Biology, Published online 23 January 2018,
  36. “A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase”, Paparella AS, Feng J, Blanco-Rodriguez B, Feng Z, Phetsang W, Blaskovich MAT, Cooper MA, Booker GW, Polyak SW, Abell AD, Tetrahedron, Published online 25 October 2017,
  37. "Structure-activity and -toxicity relationships of the antimicrobial peptide tachyplesin-1," Ingrid Edwards, Alysha Elliott, Angela Kavanagh, Mark Blaskovich, Matthew Cooper, ACS Infectious Diseases, 2017, 3(12), 917-926, doi:10.1021/acsinfecdis.7b00123
  38. “NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction,” Luís E. Pavillard, Diego Cañadas-Lozano, Elísabet Alcocer-Gómez, Fabiola Marín-Aguilar, Sheila Pereira, Avril A. B. Robertson, Jordi Muntané, Bernhard Ryffel, Matthew A. Cooper, José L. Quiles, Pedro Bullón, Jesús Ruiz-Cabello and Mario D. Cordero, Oncotarget, 2018, 8: 99740-99756, DOI: 10.18632/oncotarget.20763
  39. “Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation” Weiqiang Chen, Suan-Sin Foo, Ali Zaid, Terk-Shin Teng, Lara J. Herrero, Stefan Wolf, Kothila Tharmarajah, Luan D. Vu, Caryn van Vreden, Adam Taylor, Joseph R. Freitas, Rachel W. Li, Trent M. Woodruff, Richard Gordon, David M. Ojcius, Helder I. Nakaya, Thirumala-Devi Kanneganti, Luke A. J. O’Neill, Avril A. B. Robertson, Nicholas J. King, Andreas Suhrbier, Matthew A. Cooper, Lisa F. P. Ng & Suresh Mahalingam, Nature Microbiology, 2017, 1435-1445, DOI:10.1038/s41564-017-0015-4
  40. “Redesigned spider toxin with improved antimicrobial and anticancer properties”, Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya Ravipati, Olivier Cheneval, Aurélie Benfield, Alysha Elliott, Angela Kavanagh, Matthew Cooper, Lai Yue Chan, Yen-Hua Huang, Craik, DJ, ACS Chemical Biology, 2017, 12(9), 2324-2334, DOI: 10.1021/acschembio.7b00459
  41. “A nanoparticle-based method for culture-free bacterial DNA enrichment from whole blood”, Marwa M. Hassan, Andrea Ranzoni, and Matthew A. Cooper, Biosensors and Bioelectronics, Published online 24 July 2017 DOI:10.1016/j.bios.2017.07.057
  42. "Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors”, James R. Hill, Rebecca C. Coll, Nancy Sue, Janet C Reid, Jennifer Dou, Caroline L. Holley, Ruby Pelingon, Joshua B. Dickinson, Trevor J. Biden, Kate Schroder, Matthew A. Cooper, and Avril A. B. Robertson, Chem Med Chem, 2017, 12, 1-10, DOI: 10.1002/cmdc.201700270
  43. "Δ-Myrtoxin-Mp1a is a helical heterodimer from the venom of the Jack Jumper ant with antimicrobial, membrane disrupting and nociceptive activities”, Paul Francis Alewood, Zoltan Dekan, Stephen J Heady, Martin Scanlon, Brian A Baldo, Tzong-Hsien Lee, Marie-Isabel Aguilar, Jennifer R Deuis, Irina Vetter, Alysha G Elliott, Maite Amado, Matthew A Cooper and Dianne Alewood, Angewandte Chemie International Edition, 2017. DOI: 10.1002/anie.201703360
  44. "Investigating the interaction of octapeptin A3 with model bacterial membranes”, Han, Mei-Ling; Shen, Hsin-Hui; Hansford, Karl ; Schneider, Elena; Sivanesan, Sivashangarie; Roberts, Kade; Thompson, Philip; Le Brun, Anton; Zhu, Yan; Sani, Marc-Antoine; Separovic, Frances; Blaskovich, Mark; Baker, Mark; Moskowitz, Samuel; Cooper, Matthew; Li, Jian; Velkov, Tony, ACS Infectious Diseases, 2017, 3(8), 606-619, DOI:10.1021/acsinfecdis.7b00065
  45. “Pressor Response to Angiotensin II is Enhanced in Aged Mice and Associated with Inflammation, Vasoconstriction and Oxidative Stresse”, Quynh Nhu Dinh1, Grant R. Drummond, Barbara K. Kemp-Harper, Henry Diep, T. Michael De Silva, Hyun Ah Kim, Antony Vinh, Avril A.B. Robertson, Matthew A. Cooper, Ashley Mansell, Sophocles Chrissobolis* and Christopher G. Sobey*, Aging, 2017,  9(6), 1595-1606, DOI:10.18632/aging.101255
  46. “NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice”, Auvro R Mridha, Alexander Wree, Avril AB Robertson, Matthew M Yeh, Casey D Johnson, Derrick M Van Rooyen, Fahrettin Haczeyni, Narci C-H Teoh, Christopher Savard, George N Ioannou, Seth L Masters, Kate Schroder, Matthew A Cooper, Ariel E Feldstein, Geoffrey C Farrell, Journal of Hepatology, 2017, 66, 5, 1037-1046. DOI:10.1016/j.jhep.2017.01.022
  47. “Cryptococcus neoformans ADS lyase in an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design”, Jessical L Chitty, Kirsten L Blake, Ross D Blundell, Y.Q.Andre E Kph, Merinda Thompson, Avril Robertson, Mark S Butler, Matthew Cooper, Ulrike Kappler, Simon J Williams, Bostjan Kobe and James A Fraser, Journal of Biological Chemistry, 2017, 292, 11829-11839, DOI: 10.1074/jbc.M117.787994
  48. “Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge”, Erfei Song, James Jahng, Lisa Chong, HyeKyoung Sung, Meng Han, Cuiting Luo, Donghai Wu, Stellar Boo, Boris Hinz, Matthew Cooper, Avril Robertson, Thorsten Berger, Tak Mak, Isaac George, P Christian Schulze, Yu Wang, Aimin Xu and Gary Sweeney, American Journal of Translational Research, 2017, 9, 6, 2723-2735
  49. “Nitroimidazoles – molecular fireworks that combat a broad spectrum of infectious diseases”, Chee Wei Ang, Angie M Jarrad, Matthew A. Cooper, and Mark Arnold Thomas Blaskovich, Journal of Medicinal Chemistry, 2017, 60(18), 7636-7657, DOI: 10.1021/acs.jmedchem.7b00143
  50. "Role of the NLRP3 inflammasome in a model of acute burn-induced pain”, Jennifer R. Deuis, Kathleen Yin, Matthew A. Cooper, Kate Schroderb and Irina Vetter, Burns, 2017, 43 (2), 304-309. DOI: 10.1016/j.burns.2016.09.
  51. “Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria”, Bernd Becker, Mark S. Butler, Karl A. Hansford, Alejandra Gallardo-Godoy, Alysha G. Elliott, Johnny X. Huang, David J. Edwards, Mark A.T. Blaskovich, Matthew A. Cooper, Bioorganic & Medicinal Chemistry Letters, 2017, 27(11), 2407-2409, DOI: 10.1016/j.bmcl.2017.04.027
  52. “Polishing the tarnished silver bullet: the quest for new antibiotics”, Mark A.T. Blaskovich, Mark S. Butler and Matthew A. Cooper, Essays in Biochemistry, 2017 61, 103–114. DOI: 10.1042/EBC20160077
  53. “Institutional profile: Community for Open Antimicrobial Drug Discovery – crowdsourcing new antibiotics and antifungals”, Mathilde R Desselle, Ruth Neale, Karl A Hansford, Johannes Zuegg, Alysha G Elliott, Matthew A Cooper and Mark AT Blaskovich, Future Science, 2017, 3(2), DOI: 10.4155/fsoa-2016-0093
  54. “Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice”, C. Dempsey, A. Rubio Araiza, K.J. Bryson, O Finucane, C. Larkin, E.L. Mills, A.A.B. Robertson, M.A. Cooper, L.A.J. O'Neill, M.A. Lynch, Brain, Behavior, and Immunity, 2017, 61, 306-316, DOI: 10.1016/j.bbi.2016.12.014
  55. “Scaffolding and Completing Genome Assemblies in Real-time with Nanopore Sequencing”, Minh Duc Cao, Son Hoang Nguyen, Devika Ganesamoorthy, Alysha G. Elliott, Matthew A. Cooper and Lachlan J.M. Coin, Nature Communications, 2017, 8, 14515, DOI: 10.1038/ncomms14515
  56. “Antibacterial Nerol Cinnamates from the Australian Plant Eremophila longifolia”, Savithri Galappathie, David J. Edwards, Alysha G. Elliott, Matthew A. Cooper, Enzo A. Palombo, Mark S. Butler, and Peter J. Mahon, Journal of Natual Products, 2017, 80(4), 1178-1181, DOI: 10.1021/acs.jnatprod.6b00888
  57. “Role for NLRP3 Inflammasome-mediated, IL-1β-dependent Responses in Severe, Steroid-resistant Asthma”, Richard Y Kim, James W Pinkerton, Ama T Essilfie, Avril AB Robertson, Katherine J Baines, Alexandra C Brown, Jemma R Mayall, Md. Khadem Ali, Malcolm R Starkey, Nicole G Hansbro, Jeremy A Hirota, Lisa G Wood, Jodie L Simpson, Darryl A Knight, Peter A Wark, Peter G Gibson, Luke A. J. O'Neill, Matthew A Cooper, Jay C Horvat and Philip M Hansbro, American Journal of Respiratory and Critical Care Medicine, 2017, 43(2), 304-309, DOI: 10.1164/rccm.201609-1830OC
  58. Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action”, Joseph W. Ndieyira, Joe Bailey, Samadhan B. Patil, Manuel Vögtli, Matthew A. Cooper, Chris Abell, Rachel A. McKendry and Gabriel Aeppli, Scientific Reports, 2017, 7, 41206. DOI: 10.1038/srep41206
  59. “Small-Molecule Inhibitors of the SOX18 Transcription Factor”, Frank Fontaine, Jeroen Overman, Mehdi Moustaqil, Sreeman Mamidyala, Angela Salim, Kamesh Narasimhan, Nina Prokoph, Avril A.B. Robertson, Linda Lua, Kirill Alexandrov, Peter Koopman, Robert J. Capon, Emma Sierecki, Yann Gambin, Ralf Jauch, Matthew A. Cooper, Johannes Zuegg, Cell Chemical Biology, 2017, 24 (3), 346–359, DOI: 10.1016/j.chembiol.2017.01.003
  60. "Cationic Acrylate Oligomers Comprising Amino Acid Mimic Moieties Demonstrate Improved Antibacterial Killing Efficiency", James L. Grace, Alysha G. Elliott, Johnny X. Huang, Elena K. Schneider, Nghia P. Truong, Matthew A. Cooper, Jian Li, Thomas P. Davis, John F. Quinn, Tony Velkov and Michael R. Whittaker, Journal of Materials Chemistry B, 2017, 5, 531-536, DOI: 10.1039/C6TB02787C
  61. “Plasma protein binding structure activity relationships related to the N-terminus of daptomycin”, Elena K. Schneider, Johnny X Huang, Vincenzo Carbone, Meiling Han, Yan Zhu, Sue Nang, Keith Koo, Johnson Mak, Matthew A. Cooper, Jian Li, and Tony Velkov, ACS Infectious Diseases, 2017, 3 (3), 249–258, DOI: 10.1021/acsinfecdis.7b00015
  62. "Increased Endovascular Staphylococcus aureus Inoculum is the Link between Elevated Serum IL-10 Concentrations and Mortality in Patients with Bacteremia”, Warren Rose, Sanjay Shukla, Andrew Berti, Mary Hayney, Kelsey Henriquez, Andrea Ranzoni, Matthew Cooper, Richard A Proctoer, Victor Niet, George Sakoulas, Clinical Infectious Diseases, 2017, 64 (10), 1406-1412. DOI: 10.1093/cid/cix157
  63. “Inflammasomes in the lung”, James W. Pinkerton, Richard Y. Kim, Avril A.B. Robertson, Jeremy A. Hirota, Lisa G. Wood, Darryl A. Knight, Matthew A. Cooper, Luke A.J. O’Neill, Jay C. Horvat, Philip M. Hansbro, Molecular Immunology, 2017, 86, 44-55, DOI: 10.1016/j.molimm.2017.01.014
  64. “Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice”, Jeroen Overman, Frank Fontaine, Mehdi Moustaqil, Deepak Mittal, Emma Sierecki, Natalia Sacilotto, Johannes Zuegg, Avril A.B. Robertson, Kelly Holmes, Angela A. Salim, Sreeman Mamidyala, Mark S. Butler, Ashley S. Robinson, Wayne Johnston, Kirill Alexandrov, Brian L. Black, Benjamin M. Hogan, Sarah De Val, Robert J. Capon, Jason S. Carroll, Timothy L. Bailey, Peter Koopman, Ralf Jauch, Mark J. Smyth, Matthew A. Cooper, Yann Gambin and Mathias Francois, eLIFE, 2017, 6:e21221, DOI 10.7554/eLife.21221.001
  65. “NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice”, Auvro R. Mridha, Alexander Wree, Avril A.B. Robertson, Matthew M. Yeh, Casey D. Johnson, Derrick M. Van Rooyen, Fahrettin Haczeyni, Narci C-H. Teoh, Christopher Savard, George N. Ioannou, Seth L. Masters, Kate Schroder, Matthew A. Cooper, Ariel E. Feldstein, Geoffrey C. Farrell, Journal of Hepatology, 2017, 66, 1037–1046, DOI: 10.1016/j.jhep.2017.01.022
  66. “Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice”, José J. Fuster, Susan MacLauchlan, María A. Zuriaga, Maya Polackal, Allison Ostriker, Raja Chakravorty, Chia-Ling Wu, Soichi Sano, Sujatha Muralidharan, Cristina Rius, Jacqueline Vuong, Sophia Jacob, Varsha Muralidhar, Avril A. B. Robertson, Matthew A. Cooper, Vicente Andres, Karen K. Hirschi, Kathleen A. Martin and Kenneth Walsh, Science, 2017, 355, 842–847. DOI: 10.1126/science.aag1381
  67. “GMP Synthase is Required for Virulence Factor Production and Infection by Cryptococcus neoformans”, Jessica L Chitty, Tayla L Tatzenko, Simon J Williams, Y.Q. Andre E Koh, Elizabeth C Corfield, Mark S Butler, Avril A.B. Robertson, Matthew A Cooper, Ulrike Kappler, Bostjan Kobe and James A Fraser, The Journal of Biological Chemistry, 2017, 292, 3049-3059, DOI: 10.1074/jbc.M116.767533
  68. “Antibiotics in the Clinical Pipeline at the End of 2015”, Mark S. Butler, Mark A. T. Blaskovich and Matthew A. Cooper, The Journal of Antibiotics, 2017, 70(1), 3–24. DOI: 10.1038/ja.2016.72
  69. "Surface ligand density of antibiotic-nanoparticle conjugates enhances target avidity and membrane permeabilization of vancomycin-resistant bacteria", Marwa M. Hassan, Andrea Ranzoni, Wanida Phetsang, Mark A. T. Blaskovich, and Matthew A. Cooper, Bioconjugate Chemistry, 2017, 28 (2), 353-361, DOI: 10.1021/acs.bioconjchem.6b00494
  70. “Enhancement of antibiotic-activity through complexation with metal ions - combined ITC, NMR, enzymatic and biological studies”, Jasper S. Möhler, Theresa Kolmar, Kevin Synnatschke, Marcel Hergert, Liam A. Wilson, Soumya Ramu, Alysha G. Elliott, Mark A.T. Blaskovich, Hanna E. Sidjabat, David L. Paterson, Gerhard Schenk, Matthew A. Cooper, Zyta M. Ziora, Journal of Inorganic Biochemistry, 2017, 167, 134-141, DOI: 10.1016/j.jinorgbio.2016.11.028
  71. “From breast cancer to antimicrobial: Combating multidrug-resistant Gram-negative ‘superbugs’ using novel combinations of polymyxin B with selective estrogen receptor modulators”, Maytham H. Hussein, Elena K. Schneider, Alysha G. Elliott, Meiling Han, Felisa Reyes-Ortega, Faye Morris, Mark A. T. Blastovich, Raad Jasim, Bart Currie, Mark Mayo, Mark Baker, Matthew A. Cooper, Jian Li, and Tony Velkov, Microbial Drug Resistance, 2017, 23(5), 640-650, DOI: 10.1089/mdr.2016.0196

top of page



  1. “PB1-F2 derived from avian influenza a virus H7N9 induces inflammation via activation of the NLRP3 inflammasome”, Anita Pinar, Jennifer K Dowling, Natalie J Bitto, Avril B Robertson, Eicke Latz, Cameron R. Stewart, Grant R Drummond5, Matthew A Cooper2, Julie L McAuley, Michelle D Tate and Ashley Mansell, Journal of Biological Chemistry, 2016, 292 (3), 826-836, DOI: 10.1074/jbc.M116.756379
  1. "Emerging pathogenic links between microbiota and the gut-lung axis", Kurtis F. Budden, Shaan L. Gellatly, David L. A. Wood, Matthew A. Cooper, Mark Morrison, Philip Hugenholtz & Philip M. Hansbro, Nature Reviews Microbiology, 2016, 15, 55–63, DOI: 10.1038/nrmicro.2016.142.

  2. "The NLRP3 inflammasomefunctions as a driver of the myelodysplastic syndrome phenotype", Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu, Xianghong Chen, Joseph Johnson, Ling Zhang, Qing Zhang, Brittany A. Irvine, Thomas Cluzeau, David A. Sallman, Eric Padron, Rami Komrokji, Lubomir Sokol, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, John L. Cleveland, Luke A. O’Neill, Sheng Wei and Alan F. List, Blood, 2016, 128, 2960-2975, DOI: 10.1182/blood-2016-07-730556

  3. “The plasma protein binding proteome of ertapenem: A novel compound-centric proteomic approach for elucidating drug-plasma protein binding interactions”, Mark A. Baker, Elena K. Schneider, Johnny X. Huang, Matthew A. Cooper, Jian Li, and Tony Velkov, ACS Chemical Biology, 2016, 11 (12), 3353–3364. DOI: 10.1021/acschembio.6b00700
  4. “Identification, synthesis and biological evaluation of the major human metabolite of NLRP3 inflammasome inhibitor MCC950”, Manohar Salla, Mark S. Butler, Ruby Pelingon, Geraldine Kaeslin, Daniel E. Croker, Janet Reid, Jong Min Baek, Paul V. Bernhardt, Elizabeth M. J. Gillam, Matthew A. Cooper, and Avril A. B. Robertson, ACS Medicinal Chemistry Letters, 2016, 7 (12), 1034–1038, DOI: 10.1021/acsmedchemlett.6b00198
  5. “K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria”, Christina J. Groß, Ritu Mishra, Katharina S. Schneider, Guillaume Me´dard, Jennifer Wettmarshausen, Daniela C. Dittlein, Hexin Shi, Oliver Gorka, Paul-Albert Koenig,Stephan Fromm, Giovanni Magnani, Tamara Cikovi, Lara Hartjes, Joachim Smollich, Avril A.B. Robertson, Matthew A. Cooper, Marc Schmidt-Supprian, Michael Schuster, Kate Schroder, Petr Broz, Claudia Traidl-Hoffmann, Bruce Beutler, Bernhard Kuster, Jurgen Ruland, Sabine Schneider, Fabiana Perocchi, and Olaf Groß, Immunity, 45(4), 761-773, 2016, DOI: 10.1016/j.immuni.2016.08.010
  6. “Synthesis of multivalent [lys8]-oxytocin dendrimers that inhibit visceral nociceptive responses”, Jingjing Wan, Mehdi Mobli, Andreas Brust, Markus Muttenthaler, Åsa Andersson, Lotten Ragnarsson, Joel Castro, Irina Vetter, Johnny X. Huang, Mathias Nilsson, Stuart M. Brierley, Matthew A. Cooper, Richard J. Lewis and Paul F. Alewood, Australian Journal of Chemistry, 2016, 70, 162-171, DOI: 10.1071/CH16407

  7. "Disruption of de novo ATP biosynthesis abolishes virulence in Cryptococcus neoformans", Ross D. Blundell, Simon J. Williams, Samantha D. M. Arras, Jessica L. Chitty, Kirsten L. Blake, Daniel J. Ericsson, Nidhi Tibrewal, Jurgen Rohr, Y. Q. Andre E. Koh, Ulrike Kappler, Avril A. B. Robertson, Mark S. Butler, Matthew A. Cooper, Bostjan Kobe, and James A. Fraser, ACS Infectious Diseases, 2016, 2 (9), 651-664, DOI: 10.1021/acsinfecdis.6b00121
  8. "Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli”, Wanida Phetsang, Ruby Pelingon, Mark S. Butler, Sanjaya KC, Miranda E. Pitt, Geraldine Kaeslin, Matthew A. Cooper, and Mark A. T. Blaskovich, ACS Infectious Diseases, 2016, 2 (10), 688 - 701, DOI: 10.1021/acsinfecdis.6b00080
  9. “Streaming algorithms for identification of pathogens and antibiotic resistance potential from real-time MinIONTM sequencing”, Minh Duc Cao, Devika Ganesamoorthy, Alysha G. Elliott, Huihui Zhang, Matthew A. Cooper and Lachlan Coin, GigaScience, 2016, 5:32,
    DOI: 10.1186/s13742-016-0137-2
  10. “Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4+ T Cell Immunity”, Deshapriya S. Karunarathne, Joshua M. Horne-Debets, Johnny X. Huang, Rebecca Faleiro, Chiuan Yee Leow, Fiona Amante, Thomas Watkins, John J. Miles, Patrick J. Dwyer, Katryn J. Stacey, Mike Yarski, Chek Meng Poh, Jason Lee, Matthew A. Cooper, Laurent Renia, Derek Richard, James McCarthy, Arlene H. Sharpe and Michelle N. Wykes, Immunity, 2016, 45 (2), 333-345, DOI:10.1016/j.immuni.2016.07.017

  11. "IL-1β is an innate immune sensor of microbial proteolysis", Christopher N. LaRock, Jordan Todd, Doris L. LaRock, Joshua Olson, Avril A. Robertson, Matthew A. Cooper, Hal M. Hoffman, Victor Nizet, Science Immunology, 2016, 1 (2), pp.eaah3539,
    DOI: 10.1126/sciimmunol.aah3539
  12. "Does the Sauerbrey Equation Hold True for Binding of Peptides and Globular Proteins to a QCM? A systematic study of mass dependence of peptide and protein binding with a piezoelectric sensor." Jean E. Sohna Sohna and Matthew A. Cooper, Sensing and BioSensing Research, 11(2), 71-77, 2016, DOI: 10.1016/j.sbsr.2016.07.001
  13. “Genomic characterization of the uncultured Bacteroidalesfamily S24-7 inhabiting the guts of homeothermic animals”, Kate L. Ormerod, David L. A. Wood, Nancy Lachner, Shaan L. Gellatly, Joshua N. Daly, Jeremy D. Parsons, Cristiana G. O. Dal’Molin, Robin W. Palfreyman, Lars K. Nielsen, Matthew A. Cooper, Mark Morrison, Philip M. Hansbro, Philip Hugenholtz, Microbiome, 2016, 4 (1):36, DOI: 10.1186/s40168-016-0181-2
  14. “Semi-Synthesis and NMR Spectral Assignments of Flavonoid and Chalcone Derivatives”, Rohitesh Kumar, Yuting Lu, Alysha G. Elliott, Angela M. Kavanagh, Matthew A. Cooper and Rohan A. Davis, Magnetic Resonance in Chemistry, 2016, DOI:10.1002/mrc.4482
  15. "Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition", Michelle D Tate, James D. H. Ong, Jennifer K Dowling, Julie L McAuley, Avril AB Robertson, Eicke Latz, Grant R Drummond, Matthew A Cooper, Paul J Hertzog and Ashley Mansell, Scientific Reports, 2016, 6: 27912, DOI: 10.1038/srep27912
  16. “T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells”, Giuseppina Arbore, Erin E West, Avril A Robertson, Andreas Klos, Trent Woodruff, Luke A O'Neill, Alan Sher, Warren Leonard, Pete Monk, Matthew A Cooper, Andrew Cope, Katrin Mayer-Barber, Helen J Lachmann, Claudia Kemper, Science, 2016, 352 (6292), aad1210-aad1210-12, DOI: 10.1126/science.aad1210
  17. “Old dogs and new tricks in antimicrobial discovery”, Mark S. Butler, Mark A. T. Blaskovich, Jeremy G. Owen and Matthew A. Cooper, Current Opinion in Microbiology, 2016, 33:25-34
    DOI: 10.1016/j.mib.2016.05.011
  18. "An ‘unlikely’ pair: The antimicrobial synergy of polymyxin B in combination with the cystic fibrosis trans-membrane conductance regulator drugs KALYDECO and ORKAMBI", Elena K. Schneider, Mohammad A. K. Azad, Mei-Ling Han, Qi (Tony) Zhou, Jiping Wang, Johnny X. Huang, Matthew A. Cooper, Yohei Doi, Mark A. Baker, Phillip J. Bergen, Mark T. Muller, Jian Li, and Tony Velkov, ACS Infectious Diseases, 2016, DOI: 10.1021/acsinfecdis.6b00035
  19. “The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction”, Gerardus P.J. van Hout, Lena Bosch, Guilielmus H.J.M. Ellenbroek, Judith J. de Haan, Wouter W. van Solinge, Matthew A. Cooper,Fatih Arslan, Saskia C.A. de Jager, Avril A.B. Robertson, Gerard Pasterkamp, Imo E. Hoefer, European Heart Journal, 2016, DOI: 10.1093/eurheartj/ehw247
  20. “The ER-Mitochondria tether ERMES orchestrates fungal immune evasion, illuminating inflammasome responses to hyphal signals", Timothy Tucey, Jiyoti Verma-Gaur, Julie Nguyen, Victoria Hewitt, Tricia Lo, Miguel Shingu-Vazquez, Avril Robertson, James Hill, Filomena Pettolino, Travis Beddoe, Matthew Cooper, Thomas Naderer, and Ana Traven, mSphere - American Society for Microbiology, 2016, DOI: 10.1128/mSphere.00074-16
  21. “Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis”, Angie M. Jarrad, Anjan Debnath, Yuki Miyamoto, Karl Hansford, Ruby Pelingon, Mark S. Butler, T. Bains, Tommy Karoli, Mark. A. Blaskovich, Lars Eckmann, Matthew A Cooper, European Journal of Medicinal Chemistry, 2016, 120, 353-362, DOI: 10.1016/j.ejmech.2016.04.064
  22. “Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides”,  Ingrid A Edwards, Alysha G. Elliott, Angela M. Kavanagh, Johannes Zuegg, Mark A. T. Blaskovich and Matthew A. Cooper, ACS Infectious Diseases, 2016, DOI: 10.1021/acsinfecdis.6b00045
  23. “Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling”, Daniel E. Croker, Peter N. Monk, Reena Halai, Geraldine Kaeslin, Zoe Schofield, Mike C. L. Wu, Richard J. Clark, Mark A. T. Blaskovich, Dimitrios Morikis, Christodoulos A. Floudas, Matthew A. Cooper and Trent M. Woodruff, The Journal of Immunology & Cell Biology, 94, 787-795, 2016, DOI: 10.1038/icb.2016.43
  24. "Complete Genome Sequence of the Klebsiella quasipneumoniae subsp. similipneumoniae Strain ATCC 700603", Alysha Elliott, Devika Ganesamoorthy, Lachlan Coin, Matthew Cooper, and Minh Duc Cao, Genome Announcements – Prokaryotes, 2016, DOI: 10.1128/genomeA.00438-16
  25. “Platinum-based anticancer drugs encapsulated liposome and polymeric micelle formulation in clinical trials”, Zhou Hang, Mathew A. Cooper, Zyta M. Ziora, Biochemical Compounds, 2016, 4 (2) DOI:10.7243/2052-9341-4-2
  26. “Chemical philanthropy - a path forward for antibiotic discover?" Karl A. Hansford, Mark A.T. Blaskovich, Matthew A Cooper, Future Medicinal Chemistry, 2016, 8 (9), 925-929,
    DOI: 10.4155/fmc-2016-0029
  27. “Short cationic lipopeptides as effective antibacterial agents: design, physicochemical properties and biological evaluation”, Azmi F, Elliott A. G, Marasini N, Ramu S, Ziora Z. M, Kavanagh A. M, Blaskovich M. A. T, Cooper M. A, Skwarczynski M, Toth I, Bioorganic & Medicinal Chemistry, 2016, DOI: 10.1016/j.bmc.2016.03.053
  28. "A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance" by Daniel Watterson, Jodie Rbinson, Keith Chappell, Mark Butler, David Edwards, Scott Fry, Imogen Bermingham, Matthew Cooper, and Paul Young, Scientific Reports, 2016, 6:22791, DOI: 10.1038/srep22791
  29. “Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity”, James L. Grace, Nghia P. Truong, John F. Quinn, Johnny Huang, Matthew Cooper, Soon-Ea Cheah , Jian Li, Tony Velkov, Thomas P. Davis, Michael R. Whittaker, RSC Advances, 2016, DOI: 10.1039/C5RA24361K
  30. “Human Monocytes Engage an Alternative Inflammasome Pathway”, Moritz M. Gaidt, Thomas S. Ebert, Dhruv Chauhan, Tobias Schmidt, Jonathan L. Schmid-Burgk, Francesca Rapino, Avril A. B. Robertson, Matthew A. Cooper and Veit Hornung; Immunity, 2016,
    DOI: 10.1016/j.immuni.2016.01.012
  31. “Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B", Gallardo-Godoy, Alejandra; Muldoon, Craig; Becker, Bernd; Elliott, Alysha; Lash, Lawrence; Huang, Johnny; Butler, Mark; Pelingon, Ruby; Kavanagh, Angela; Ramu, Soumya; Phetsang, Wanida; Blaskovich, Mark; Cooper, Matthew, Journal of Medicinal Chemistry, 2016, DOI: 10.1021/acs.jmedchem.5b01593



  1. “Novel compound cytokine release inhibitory drug 3 (CRID3) inhibits the NLRP3 inflammasome in rheumatoid arthritis”, T McGarry, RC Coll, AAB Robertson, MA Cooper, LA O’Neill, DJ Veale, U Fearon, Annals of the Rheumatic Diseases, 2015, 74, A62-A63, DOI:10.1136/annrheumdis-2015-207259.144
  2. “A community-based approach to new antibiotic discovery”, Matthew A Cooper, Nature Reviews Drug Discovery, 2015, 14 (9), 587–588, DOI: 10.1038/nrd4706
  3. “Carbohydrate scaffolds as glycosyltransferase inhibitors with in vivo antibacterial activity” J. Zuegg , C. Muldoon, G. Adamson, D. McKeveney, G.L. Thanh, R. Premraj, B. Becker, M. Cheng, A. Elliott , J. Huang, M.S. Butler, M. Bajaj, J. Seifert, L. Singh, N. Galley, D. Roper, A. Lloyd, C. Dowson, T.-J. Cheng, W.-C. Cheng, D. Demon, E. Meyer, W. Meutermans  and M.A. Cooper. Nature Communications, 2015, 6:7719, DOI: 10.1038/ncomms8719
  4. “A small molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases,” R.C. Coll, A.A.B. Robertson, J.J. Chae, S.C.. Higgins, R. Muñoz-Planillo, M.C.. Inserra, I. Vetter, L.S.. Dungan, B.G.. Monks, A. Stutz, D.E. Croker, M.S. Butler, M. Haneklaus, C.E. Sutton, G. Núñez, E. Latz, D.L. Kastner, K.H.G. Mills, S.L. Masters, K. Schroder, MA Cooper, L.A.J. O’Neill, Nature Medicine, 2015, 21, 248-255,
    DOI: 10.1038/NM.3806
  5. “Antibacterial and antifungal screening of natural products sourced from Australian fungi and characterisation of pestalactams D–F”, Karren D. Beattie, Nicola Ellwood, Rohitesh Kumar, Xinzhou Yang, Peter C. Healy, Vanida Choomuenwai, Ronald J. Quinn, Alysha G. Elliott, Johnny X. Huang, Jessica L. Chitty, James A. Fraser, Matthew A. Cooper, Rohan A. Davis, Phytochemistry,2015, 124, 79-85, DOI: 10.1016/j.phytochem.2015.12.014
  6. “The Effect of Novel Compound MCC950 on the NLRP3 Inflammasome in the RA Joint”,  T. McGarry, A.A. Robertson, C. Orr, R.C. Coll, M.A. Cooper, L.A. O'Neill, D.J. Veale and U. Fearon, Annals of the Rheumatic Diseases, 2015, 74(suppl 2), 202 2-202, DOI: 10.1136/annrheumdis-2015-eular.3985
  7. “Activation of redox-sensitive inflammasomes underlies the biological phenotype of myelodysplastic syndromes”, A. Basiorka, K. Mcgraw, E. Eksioglu, X. Chen, J. Johnson, E. Padron, R. Komrokji, L. Sokol, R. Coll, L. O'Neill, M. Cooper, A. Robertson, S. Wei and A. List, Leukemia Research, 2015, 32, S14, DOI: 10.1016/S0145-2126(15)30033-3
  8. “Realtime analysis and visualisation of MinION sequencing data with npReader”, Minh Duc Cao, Devika Ganesamoorthy, Matthew A. Cooper and Lachlan J. M. Coin, Bioinformatics, 2015, DOI: 10.1093/bioinformatics/btv658
  9. “An optimized whole blood assay measuring expression and activity of NLRP3-, NLRC4 and AIM2-inflammasomes”, L Grinstein, H Luksch, AAB Robertson, MA Cooper, S Winkler, & A Rösen-Wolff, Pediatr Rheumatol Online J., 2015, 13(Suppl 1): O51,
    DOI: 10.1186/1546-0096-13-S1-O51
  10. “Clostridium difficile infection: current and emerging therapeutics”, Angie M. Jarrad, Mark A. T. Blaskovich, Dena Lyras, Matthew A. Cooper, Current Treatment Options in Infectious Diseases, 2015, 7 (4) 317-334, DOI: 10.1007/s40506-015-0062-4
  11. "Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection", Paula Antunes, Daniel Watterson, Mattias Parmvi, Robert Burger, Anja Boisen, Paul Young, Matthew A. Cooper, Mikkel F. Hansen, Andrea Ranzoni & Marco Donolato, Scientific Reports, 2015, 5 (16145) 1-10, DOI: 10.1038/srep16145
  12. “Inflammasomes in COPD and neutrophilic asthma”, Richard Y Kim, James W Pinkerton, Peter G Gibson, Matthew A. Cooper, Jay C Horvat, Philip M Hansbro, Thorax, 2015, 70 (12), 1199-1201, DOI: 10.1136/thoraxjnl-2014-206736
  13. “Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites”, Angie M. Jarrad, Tomislav Karoli, Anjan Debnath, Chin Yen Tay, Johnny X. Huang, Geraldine Kaeslin, Alysha G. Elliott, Yukiko Miyamoto, Soumya Ramu, Angela M. Kavanagh, Johannes Zuegg, Lars Eckmann, Mark A.T. Blaskovich, Matthew A. Cooper, European Journal of Medicinal Chemistry, 2015, 101, 96-102,
    DOI: 10.1016/j.ejmech.2015.06.019
  14. “Shaping Nanoparticles with Hydrophilic Compositions and Hydrophobic Properties as Nanocarriers for Antibiotic Delivery”, Yusilawati Ahmad Nor, Yuting Niu, Surajit Karmakar, Liang Zhou, Chun Xu, Jun Zhang, Hongwei Zhang, Meihua Yu, Donna Mahony, Neena Mitter, Matthew A. Cooper, and Chengzhong Yu, ACS Cent. Sci., 2015,
    DOI: 10.1021/acscentsci.5b00199
  15. “Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains”, Fazren Azmi, Alysha G Elliott, Zeinab G Khalil, Waleed M Hussein Angela Kavanagh, Johnny X Huang, Michelle Quezada, Mark A T Blaskovich, Robert J Capon, Matthew A Cooper, Mariusz Skwarczynski1, Istvan Toth, Nanomedicine, 2015, DOI: 10.2217/nnm.15.137
  16. “Flemingin-Type prenylated chalcones from the Sarawak rainforest plant Desmodium congestum”, K.A. Rees, C. Bermudez, D.J. Edwards, AG. Elliott, J.E. Ripen, C. Seta, J.X. Huang, M.A. Cooper, J.A. Fraser, T.C. Yeo and M.S. Butler, J.Nat. Prod., 2015, 78 (8), 2141–2144,
    DOI: 10.1021/acs.jnatprod.5b00410
  17. “NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5”, Paul J. Baker, Dave Boucher, Damien Bierschenk, Christina Tebartz, Paul G. Whitney, Damian B. D'Silva, Maria C. Tanzer, Mercedes Monteleone, Avril A. B. Robertson, Matthew A. Cooper, Silvia Alvarez-Diaz, Marco J. Herold, Sammy Bedoui, Kate Schroder and Seth L. Masters, 2015, European Journal of Immunology, 45 (10), 2918 – 2926, DOI: 10.1002/eji.201545655
  18. “Mucin binding reduces colistin antimicrobial activity”, J.X. Huang, M.A.T. Blaskovich, R. Pelingon, S. Ramu A. Kavanagh, A.G. Elliott, M.S. Butler, A.B. Montgomery & M.A. Cooper. Antimicrobial Agents and Chemotherapy, 2015, 59 (10), 5925 - 5931, DOI: 10.1128/AAC.00808-15
  19. “Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice”, S.M. Krishnan, J.K. Dowling, Y.H. Ling, H. Diep, C.T. Chan, D. Ferens, M.M. Kett, A. Pinar, C.S. Samuel, A. Vinh, T.V. Arumugam, T.D. Hewitson, B.K. Kemp-Harper, A.A.B. Roberston, M.A. Cooper, E. Latz, A. Mansell, C.G. Sobey, G.R. Drummond. British J. Pharmacol., 2015, 173 (4), 752 – 765, DOI: 10.1111/bph.13230
  20. “Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli”, Kolja Schaale, Kate M. Peters, Anna K. Fritzsche, Minh-Duy Phan, Makrina Totsika, Avril A.B. Robertson, Katie B. Nichols, Matthew A. Cooper, Glen C. Ulett, Katryn J. Stacey, Kate Schroder, Mark A. Schembri, Matthew J Sweet. Mucosal Immunology, 2015, 9 (1), 124-136, DOI: 10.1038/mi.2015.44
  21. “Molecular  characterization of the hemagglutinin glycan-binding specificity of egg-adapted vaccine strains of the pandemic 2009 H1N1 swine influenza A virus”, Vince Carbone, Elena K. Schneider, Steve Rockman, Mark Baker, Johnny Huang, Matthew Cooper, Chi Ong, Elizabeth Yuriev, Paul Ramsland, Jian Li, Tony Velkov, Molecules, 2015,  20 (6), 10415-10434, DOI: 10.3390/molecules200610415
  22. “Improved Immunoassay Sensitivity in Serum as a Result of Polymer- Entrapped Quantum Dots: ‘Papaya Particles” A. Razoni, A. den Hamer, T. Karoli, J. Buechler & M.A. Cooper, Anal. Chem., 2015, 87 (12), 6150 – 6157, DOI: 10.1021/acs.analchem.5b00762
  23. “Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics—polymyxin B and chloramphenicol”, Nusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D. Johnson, Heidi Yu, Hanna E. Sidjabat, John Boyce, Mark Butler, Matthew Cooper, Jing Fu, David L. Paterson, Roger L. Nation, Phillip J. Bergen, Tony Velkov, Jian Li, JAC, 28 May 2015, 70 (9), 2589-2597, DOI: 10.1093/jac/dkv135
  24. “Helping chemists discover new antibiotics”, M.A.T. Blaskovich, J. Zuegg, A.G. Elliott & M.A. Cooper, ACS Infectious Diseases, 2015, 1(7), 3, DOI: 10.1021/acsinfecdis.5b00044
  25. “Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agents”, S.M. Hickey, T.D. Ashton, S.K. Khosa, R.N. Robson, J.M. White, J. Li, R.L. Nation, H.Y. Yu, A.G. Elliott, M.S. Butler, J.X. Huang, M.A. Cooper & F.M. Pfeffer, Organic & Molecular Biochemistry, 2015, 13 (22), 6225-41, DOI: 10.1039/C5OB00621J
  26. “Ethanol concentration influences the mechanisms of wine tannin interactions with poly(L-proline) in model wine”. Jacqui M. McRae, Zyta M. Ziora, Stella Kassara, Matthew A. Cooper, and Paul A. Smith. Journal of Agricultural and Food Chemistry, 2015, 63 (17), 4345-4352, DOI: 10.1021/acs.jafc.5b00758
  27. “Urinary Biomarkers for Detection of Early and Advanced Chronic Kidney Disease-A Pilot Study”, Vlasta Korenkova, Alun Jones, Wendy E Hoy, Christudas Morais, Matthew A Cooper, Glenda C Gobe, Medicinal Chemistry, 2015, 5:096-103,
    DOI: 10.4172/2161-0444.1000249
  28. “Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells”, J. X. Huang, G. Kaeslin, M.V. Ranall, M.A. Blaskovich, B. Becker, M. S. Butler, M.H. Little, L. Lash & M.A. Cooper, Pharmacology Research & Perspectives, 2015, 3 (3), 14,DOI: 10.1002/prp2.148
  29. “Synthesis of norbornane bisether antibiotics via silver-mediated alkylation”, S.M. Hickey, T.D. Ashton, J.M. White, J. Li, R.L. Nation, H.Y. Yu, A.G. Elliott, M.S. Butler, J.X. Huang, M.A. Cooper & F.M. Pfeffer, RSC Advances, 2015, 5 (36), 28582-28596,
    DOI: 10.1039/C5RA03321G
  30. Clostridium difficile drug pipeline: challenges in discovery and development of new agents” A. Jarrad, T. Karoli, M.A. Blaskovich, D. Lyras & M.A. Cooper. J. Med. Chem., 2015, 58 (13), 5164 – 5185, DOI: 10.1021/jm5016846
  31. “QCM-based rapid analysis of DNA” F.N. Dultsev, E.A. Kolosovsky, M.A. Cooper, A.A. Lomzov, D.V. Pyshnyi, Sens. Biosens. Res., 2015, 4, 11-15,
  32. “α-Conotoxin dendrimers have enhanced potency and selectivity for nicotinic acetylcholine receptors”, J. Wan, J.X. Huang, I. Vetter, M. Mobli, J. Lawson, H.S. Tae, N. Abraham, P. Blessy, M.A. Cooper, D. Adams, R. Lewis & P. Alewood, J. Am Chem Soc., 2015, 137 (9), 3209-3212, DOI: 10.1021/jacs.5b00244
  33. “A new antibiotic with potent activity against Gram-positive bacteria targets MscL”. I. Iscla, R. Wray, P. Blount, J. Larkins-Ford, A.L. Conery, F.M. Ausubel, S. Ramu, A. Kavanagh, J.X. Huang, M.A. Blaskovich, M.A. Cooper, A. Obregon-Henao, I Orme, E.S. Tjandra, U. Stroeher, M. Brown, C. Macardle, N. van Holst, C.L. Tong, A.D. Slattery, C.T. Gibon, C.L. Raston & R.A. Boulos. J. Antibiotics, 2015, 68, 453-462, DOI: 10.1038/ja.2015.4
  34. “Discovery of novel Pneumococcal surface antigen A (PsaA) inhibitors using a fragment-based drug design approach”, M. Bajaj, S. Mamidyala,, J. Zuegg, S. Begg, M. Ween, J.X. Huang, A. McEwan, B. Kobe, J. Pton, C. McDevitt & M.A. Cooper, ACS Chemical Biology, 2015, 10 (6), DOI: 10.1021/cb501032x
  35. “Facile synthesis of mono- and bis-methylated Fmoc-Dap, -Dab and –Orn building blocks”, F. Lindahl, H. Huang, D.P.Fairlie & M.A. Cooper, Chem. Comms., 2015, 51, 4496-4498 Advance Article,  51 (21), 4496-4498, DOI: 10.1039/C4CC09780G
  36. “Drug-drug plasma protein binding interactions of ivacaftor”, E. Schneider, J. Huang, V. Carbone, M. Baker, J. Striessnig, M. Azad, M.A. Cooper, J. Li. J. Molec. Recog., 2015, 28 (6), 339-348, DOI: 101002/jmr.2447
  37. “Affinities and in-plane stress forces between glycopeptide antibiotics and biomimetic bacterial membranes.” S. Bi, A. Ranzoni, J.X. Huang, K. Hansford & M.A. Cooper, Sensing and Bio-Sensing Research, 2015, 3, 24-30, DOI: 10.1016/j.sbsr.2014.10.003
  38. “Evaluation of direct and multi-layer passivation and capture chemistries for nanoparticle-based biosensor applications.” S. KC, A. Ranzoni & M.A. Cooper, Biosensors & Bioelectronics. 2015, 67, 769-774, DOI: 10.1016/j.bios.2014.09.048

  top of page


  1. “Cell- and biomarker-based assays for predicting nephrotoxicity”. J. Huang, M.A. Blaskovich &  M.A. Cooper. Expert Opinion on Drug Metabolism & Toxicology. 2014, 10 (12) 1621-1635 DOI: 10.1517/17425255.2014.967681
  2. “Ramoplanin at bacterial concentrations induces bacterial membrane depolarization in Staphylococcus aureus”, M. Cheng, J.X. Huang, S. Ramu, M.S. Butler and M.A. Cooper, Antimicrob Agents and Chemo. 2014, 58(11) 6819-6827, DOI: 10.1128/AAC.00061-14
  3. “Derivations of ligands for the complement C3a receptor from the C-terminus of C5a”, R. Halai, M.L. Bellows-Petersen, W. Branchett, J. Smadbeck, C.A. Kieslich, D.E. Croker, M.A. Cooper, D. Morikis, T.M. Woodruff, C.A. Floudas & P.A. Monk. European J Pharmacol. 2014, 745, 15 Dec, 176-181, DOI: 10.1016/j.ejphar.2014.10.041
  4. “Natural product and natural product derived drugs in clinical trials”. M.S. Butler, A.A.B. Robertson & M.A. Cooper. Natural Product Reports. 2014, 31, 1612 – 1661,
    DOI: 10.1039/C4NP00064A
  5. “Glycopeptide Antibiotics: Back to the Future”, M.S. Butler, K.A. Hansford, M.A. Blaskovich & M.A. Cooper, Journal of Antibiotics 2014, 67, 631-644, DOI: 10.1038/ja.2014.111
  6. “Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction”,  C.J. Greenhill, G.W. Jones, M.A. Nowell, A.K. Harvey, A.N. Moiden, F.L. Collins, A.C. Bloom, R.C. Coll, A.B. Robertson, M.A. Cooper, M. Rosas, P.R. Taylor, L.A. O’Neill, I.R. Humphreys, A.S. Williams & S.R. Jones. Arthritis Research & Therapy, 2014, 16, 419 - 428, DOI: 10.1186/s13075-014-0419-y
  7. “An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants” W. Phetsang, M.A. Blaskovich & M.A. Cooper Biorg Med Chem. 2014, 22, 4490-4498, DOI: 10.1016/j.bmc.2014.05.054
  8. “Pathway-selective antagonism of proteinase activated receptor 2”. J.Y. Suen, A. Cotterell, R.-J. Lohman, J. Lim, A. Han, M.-K. Yau, L. Liu, M.A. Cooper, D.A. Vesey, & D.P. Fairlie.  Brit. J. Pharmacol. 2014, 171 (17), 4112-4124, DOI: 10.1111/bph.12757
  9. “C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and b-arrestin recruitment”, D.E. Croker, R. Halai, G. Kaeslin, E. Wende, B. Fehlhaber, A. Klos, P. Monk & M.A. Cooper. Immunol. Cell Biol. 2014, (92), 631-639,
    DOI: 10.1038/icb.2014.32
  10. “Surface stress sensors for rapid and ultrasensitive detection of active free drugs in human serum”,  J.W. Ndieyira, N. Kappeler, S. Logan, M.A. Cooper, C. Abell, R.A. McKendry & G. Aeppli, Nature Nanotechnology. 2014, 9, 225 - 232. DOI: 10.1038/nnano.2014.33
  11. “Monoacetylation of carbohydrate diols via trans-esterification with ethyl acetate” X. Lu, B. Becker & M.A. Cooper, Australian Journal of Chemistry. 2014, 67, 679-683,
    DOI:  10.1071/CH12518
  12. “Anti-cooperative ligand binding and dimerization in the glycopeptide antibiotic dalbavancin”, M. Cheng, Z. Ziora, K. Hansford, M.A. Blaskovich, M.S. Butler & M.A. Cooper. Organic & Biomol. Chem. 2014, 12 (16), 2568-2575, DOI: 10.1039/c3ob42428f
  13. “Natural product libraries: assembly, maintenance and screening”, M.S. Butler, F.R. Fontaine & M.A. Cooper. Planta Medica. 2014, 80, 1161-1170, DOI: 10.1039/C4NP00064A
  14. “Imperfect coordination chemistry facilititates metal ion release in the Psa permease”, R. M. Counago, M.P. Ween, S.L. Begg, M. Bajaj, J. Zuegg, M.L. O’Mara, M.A. Cooper, A.G. McEwan, J.C. Paton, B. Kobe, and C.A. McDevitt, Nature Chem Biol, 2014; 10, 35-41,
    DOI: 10.1038/nchembio.1382



  1. “Fine tuning the disassembly time of thermoresponsive polymer nanoparticles”. Nguyen T.D. Tran, Z. Jia, N.T. Phuoc, M.A.Cooper, M.J. Monteiro. Biomacromol., 2013, 14(10): 3463-471, DOI: 10.1021/bm4007858
  2. "C5a, but not C5a-des Arg induces upregulation of heteromer formation between its complement C5a receptors C5aR and C5L2”, D.E. Croker, R. Halai, D.P. Fairlie, M.A. Cooper. Immunol & Cell Biol., 2013, 91(10): 625-33, DOI: 10.1038/icb.2013.48
  3. "Neutrophils: a key component of ischemia reperfusion injury”, Z.V. Schofield, T.M. Woodruff, R. Halai, M. C-L Wu, M.A. Cooper. Shock, 2013, 40 (6): 463-70,
    DOI: 10.1097/SHK.0000000000000044
  4. “Nanoparticle sample preparation and mass spectrometry for rapid diagnosis of microbial infections” A. Ranzoni, H. Sidjabat and M.A. Cooper. Microbiology Australia, 2013, 34 (4), 170-174, DOI: 10.1071/MA13057
  5. “Probing the reactivity of o-phthalaldehydic acid/methyl ester: synthesis of N-isoindolinones and 3-arylaminophthalides”. S.K. Mamidyala and M.A. Cooper. Chem. Comm. 2013, 49(75): 8407-409, DOI: 10.1039/C3CC43838D
  6. “Antibiotics in the clinical pipeline in 2013”, M.S. Butler, M.A. Blaskovich and M.A. Cooper,
    J. Antibiot., 2013,  66(10): 571-91, DOI: 10.1038/ja.2013.86
  7. “In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?” S.J. van Hal, J.A. Steen, B.A. Espedido, S.M.Grimmond, M.A. Cooper, M.T.G. Holden, S.D. Bentley, I.B. Gosbell & S.O. Jensen. Journal of Antimicrobial Chemotherapy. 2013, 69(2): 363-67, DOI: 10.1093/jac/dkt354
  8. “Comparison of surface plasmon resonance, resonant waveguide grating biosensing and ELISA in the evaluation of a Dengue virus immunoassay”. D. Hu, S.R. Fry, J.X. Huang, X. Ding, L. Qiu, Y. Pan, Y. Chen, J. Jin, C. McElnea, J. Buechler, X. Che, & M.A. Cooper. Biosensors, 2013, 3, 297-311, DOI: 10.3390/bios3030297
  9. “A paramagnetic-reporter two-particle system for amplification-free detection of DNA in serum”. D.A.C. Thomson and M.A. Cooper. Biosensors and Bioelectronics. 2013, 50, 499-501,
  10. “The antigenic architecture of the hemagglutinin of influenza H5N1 viruses” T. Velkov, C. Ong, M.A. Baker, H. Kim, J. Li, R.L. Nation, J.X. Huang, M.A. Cooper and S. Rockman. Molecular Immunology, 2013, 56(4): 705-719.
  11. “Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae” by T. Velkov, Z.Z. Deris, J. Huang, M. Azad, C. Dong, B. Boyd, M. Baker, M.A. Cooper, R. Nation, and J. Li. Innate Immunity, E-pub ahead of print 25 July 2013,
    DOI: 10.1177/1753425913493337
  12. “Molecular characterization of the receptor binding structure-activity relationships of influenza B virus hemagglutinin”, V. Carbone, H. Kim, J.X. Huang, M.A/ Baker, C. Ong, M.A. Cooper, J. Li, S. Rockman, T. Velkov. Acta virologica, 2013, 57(3): 313-352, DOI: 10.4149/av_2013_03_313
  13. “The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes”, R.C. Coll, A.A.B. Robertson, M.S. Butler, M.A. Cooper, L.A.J. O'Neill, Plos One, 6(12): e29539. 2013, DOI: 10.1371/journal.pone.0029539
  14. "Antibacterial serrulatane diterpenes from the Australian native plant Eremophila microtheca”, E.C. Barnes, A.M. Kavanagh, S. Ramu, M.A. Blaskovich, M. A. Cooper, and R.A. Davis, Phytochemistry, 2013, 93, 162-169, DOI: 10.1016/j.phytochem.2013.02.021
  15. “Whole Genome Sequence Analysis of the First Australian OXA-48-Producing Outbreak-Associated Klebsiella pneumoniae Isolates: The Resistome and in vivo Evolution”, B. Espedido, J. Steen, H. Ziochos, S. Grimmond, M.A Cooper; I. Gosbell, S. van Hal, S. Jensen. Plos One, 2013, 8 (3) e59920, DOI: 10.1371/journal/pone.0059920
  16. “Efficient synthesis of anacardic acid analogues and their antibacterial activities”, S.K. Mamidyala, S. Ramu, J.X. Huang, A.B. Robertson, M.A. Cooper, Bioorg Med Chem Lett, 2013, 23 (6): 1667-670, DOI: 10.1016/j.bmcl.2013.01.074
  17. “Timed-release polymer nanoparticles”, T.D.T. Nguyen, N.P. Truong, W. Gu, Z. Jia,  M.A. Cooper, M.J. Monteiro, Biomacromolecules. 2013, 14(2), 495-502, DOI: 10.1021/bm301721k
  18. “Vancomycin: Ligand recognition, Dimerization and Super-complex Formation”, Z. Jia, M, O'Mara, J. Zuegg, M.A. Cooper, A. Mark, FEBS, 2013, 280 (5)1294-30, DOI: 10.1111/febs.12121
  19. “Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumonia strains with under-acylated lipid A”, T. Velkov, R.L. Soon, P.L. Chong, J.X. Huang, M.A. Cooper, M.A.K. Azad, P.E. Thompson, K. Roberts, R.L. Nation, A. Clements, R.A. Strugnell & J. Li. Innate Immunity. 2013, 19(3): 265-77, DOI: 10.1177/1753425912459092



  1. "Aminoglycoside antibiotics in the 21st Century”, B. Becker, M.A. Cooper, ACS Chem Biol, 2012, 8(1), 105-115, DOI: 10.1021/cb3005116
  2. "Variation of the net charge, lipophilicity and side chain flexibility in Dmt1-DALDA: effect on opioid activity and biodistribution“ A. Novoa, S. Van Dorpe, E. Wynendaele, M. Spetea, N. Bracke, S. Stalmans, C. Betti, N. Chung, C. Lemieux, J. Zuegg, M. A. Cooper, D. Tourwé, B. De Spiegeleer, P. Schiller, S. Ballet, J. Med Chem, 2012, 55(22), 9549-61,
    DOI: 10.1021/jm3008079
  3. “Tumour-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients” D.A. Ovchinnikov, M.A. Cooper, P. Pandit, W.B. Coman, J.J. Cooper-White, P. Keith, E.J. Wolvetang, P.D. Slowey & C. Punyadeera, Transl Oncol., 2012, 5(5):321-6,
    DOI: 10.1593/tlo.12232
  4. “Lipoamino acids as major components of absorption promoters in drug delivery”, Z.M. Ziora, M.A. Blaskovich, I. Toth & M.A. Cooper. Curr Topics in Med Chem, 2012, 12(14):1562-80, DOI: 10.2174/156802612802652448
  5. “Drug-Likeness and increased hydrophobicity of commercially available compound libraries for drug screening”, J. Zuegg & M.A. Cooper. Curr Topics Med Chem, 2012, 12(14), 1500-13, DOI: 10.2174/156802612802652466
  6. “Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry”, T. Velkov, M.A.K. Azad, J.X. Huang, M.A. Cooper, N. M. Ching, R.L. Nation & J. Li. J. Mol. Recognit. 2012, 25(12), 642-56, DOI: 10.1002/jmr.2221
  7. “Identification of anti-tubercular benzothiazinone compounds by ligand-based design”, T. Karoli, B.Becker, J. Zuegg, U. Mollmann, S. Ramu, J.X. Huang & M.A. Cooper, J Med Chem, 2012, 55(17):7940-4, DOI: 10.1021/jm3008882
  8. “Resolving biofilm infections: Current therapy and drug discovery strategies”, M.V. Ranall, M.S. Butler, M.A. Blaskovich & M.A. Cooper. Curr. Drug Targets. 2012, 13(11), 1375-85,
    DOI: 10.2174/138945012803530251
  9. “A survey of the 2010 Quartz Crystal Microbalance literature”, R.E. Speight & M.A. Cooper. J Mol. Recognit., 2012, 25(9):451-73, DOI: 10.1002/jmr.2209
  10. “Molecular characterization of lipopolysaccharide binding to human α-1-acid glycoprotein”, J.X. Huang, M.A.K. Azad, R.L. Nation, J. Li, M.A. Cooper & T. Velkov. Journal of Lipids: Bacterial Lipids, 2012, 475153, DOI: 10.115/2012/475153
  11. “Development of anti-infectives using phase display: Biological agents against bacteria, viruses and parasites”, J.X. Huang, S.L. Bishop-Hurley, M.A. Cooper, Antimicrob Agents Ch, 2012, 56(9), 4569-82, DOI: 10.1128/AAC.00567-12
  12. “A comparative study of impedance versus optical label-free systems relative to labelled assays in a predominantly Gi coupled GPCR (C5aR) signalling”, R. Halai, D. Croker, J.Y. Suen, D.P. Fairlie & M.A. Cooper, Biosensors, 2012, 2, 273-290, DOI: 10.3390/bios2030273
  13. “Oligonucleotide and polymer functionalized nanoparticles for amplification-free detection of DNA”, D.A.C. Thomson, E.H-L. Tee, N.T.D. Tran, M.J. Monteiro & M.A. Cooper. Biomacromolecules. 2012, 13, 1981-1989, DOI: 10.1021/bm300717f
  14. “Structure-activity relationships for the binding of polymyxin antibiotics with human a-1-acid glycoprotein”. M.A.K. Azad, J.X. Huang, M.A. Cooper, K.D. Roberts, P.E. Thompson, J. Li, R.L. Nation, T. Velkov. Molecular Pharmaceutics, 2012, 84(3), 278-91,
    DOI: 10.1016/j.bcp.2012.05.004
  15. “Carriage of an ACME II Variant has contributed to MRSA ST239-like Strain Replacement in Liverpool Hospital, Sydney, Australia.” B. Espedido, J. Steen, T. Barbagiannakos, J. Mercer, D. Paterson, S. Grimmond, M.A. Cooper, I. Gosbell, S. vanHal & S. Jensen. Antimicrob Agents Ch. 2012, 56(6), 3380-3383, DOI: 10.1128/AAC.00013-12
  16. “The changing face of screening and drug discovery, Screening Asia 2011 Singapore: Conference Report.” M.A. Cooper. Exp. Rev. Proteomics, 2012, 9(2), 123-124,
    DOI: 10.1586/EPR.12.7
  17. "Structure aided design of chimeric antibiotics”, T. Karoli, S.K. Mamidyala, J. Zuegg, S.R. Fry, E.H-L. Tee, T.A. Bradford, P.K. Madala, J.X. Huang, S. Ramu, M.S. Butler & M.A. Cooper, Bioorganic & Medicinal Chemistry Letters, 2012  22, 2428-2433, DOI: 10.1016/j.bmcl.2012.02.019
  18. “Measurement of Drug Lipophilicity and pKa Using Acoustics”, X. Li & M.A. Cooper, Anal Chem. 2012 84(6), 2609-2613, DOI: 10.1021/ac300087z
  19. "Using label-free screening technology to improve efficiency in drug discovery”, R. Halai & M.A. Cooper, Expert Opinion on Drug Discovery, 2012, 7 (2), 123-131,
    DOI: 10.1517/17460441.2012.651121
  20. “Screening strategies to identify new antibiotics” M. S. Butler and M. A. Cooper, Current Drug Targets, 2012, 13(3), 373-387, DOI: 10.2174/138945012799424624

top of page



  1. “The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II”,Z-G. Jia, M. O’Mara, J. Zuegg, M.A.Cooper & A. Mark, The Biophysical Journal, 2011, 101 (11), 2684-2692, DOI: 10.1016/j.bpj.2011.10.047
  2. “Fluorogenic pyrosequencing in microreactors”, J.A. Steen & M.A. Cooper, Nature Methods, 8 (7) July 2011, 548-549, DOI: 10.1038/nmeth.1634
  3. "Antibiotics in the clinical pipeline", M.S. Butler and M.A. Cooper, Journal of Antibiotics, 2011, 64, 413-425, DOI: 10.1038/ja.2011.44
  4. "The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach", S.R. Fry, M. Meyer, M.G. Semple, C.P. Simmons, S.D. Sekaran, J. X. Huang, C. McElnea, C-Y. Huang, A. Valks, P.R. Young and M.A. Cooper, PLoS NTD, 2011, 5 (6) 1-8, DOI: 10.1371/journal.pntd.0001199
  5. "Fix the antibiotic pipeline" M.A. Cooper & D.A. Shlaes, Nature, 7 April 2011 472, 32,
    DOI: 10.1038/472032a
  6. "Cyclizations using selenium chemistry for substituted 3-hydroxypiperidines and 3-hydryxopyrrolidines" M.A. Cooper and A. David Ward, Aust. J. Chem. 2011, 64, 1327-1338, DOI: 10.1071/CH11073
  7. "Biomarkers in Chronic Kidney Disease: a Review" R.G. Fassett, S.K. Venuthurupalli, G.C. Gobe, J.S. Coombes, M.A. Cooper and W. Hoy, Am. J. Kidney International. 2011, 80, 806-821, DOI: 10.1038/ki.2011.198
  8. “Separation and detection of bacteria using rupture event scanning” M.A. Cooper, F. N. Dultsev, V.P. Ostanin, D. Klenerman, Analytica Chimica Acta 2011, 702,233-238,
    DOI: 10.1016/j.aca.2011.06.025
  9. “A survey of the 2006-2009 quartz crystal microbalance biosensor literature”, M.A. Cooper and B. Becker, Journal of Molecular Recognition, 2011, 24, 754-787, DOI: 10.1002/jmr.1117
  10. "Amplification free detection of herpes simplex virus DNA from cerebrospinal fluid" D.A.C. Thomson, K. Dimitrov and M.A. Cooper, Analyst, 2011, 136 (8), 1599,
    DOI: 10.1039/c0an01021a
  11. "Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, maculatin", B.C.S. Chia, Y. Gong, J.H. Bowie, J. Zuegg and M.A. Cooper, Biopolymers: Peptide Science, 2011, 96(2), 147-157, DOI: 10.1002/bip.21438



  1. “The synthesis of Essramycin and comparison of its antibacterial activity”, E. H-L. Tee, T. Karoli, S. Ramu, J.X. Huang, M.S. Butler and M. A. Cooper, Journal of Natural Products, 2010, 73 (11), 1940-1942, DOI: 10.1021/np100648q
  2. “Positive frequency shifts observed upon adsorbing micron-sized solid objects to a quartz crystal microbalance from the liquid phase”, A. Pomorska, D. Shchukin, R. Hammond, M.A. Cooper, G. Grundmeier, D. Johannsmann, Anal. Chem., 2010, 82 (6), 2237-2242,
    DOI: 10.1021/ac902012e
  3. “A signal amplification for HSV type 1 viral DNA detection using nanoparticles and direct acoustic profiling”, Y. Uludag, R. Hammond, M.A. Cooper, J. Nanobiotechnol., 2010, 8 (3),
    DOI: 10.1186/1477-3155-8-3, ISI Highly Accessed article
  4. “How to stress superbugs”, M.A. Cooper Australasian Sci., 2010, 31 (2), 31-32.
  5. “Vancomycin dimer formation between analogues of bacterial peptidoglycan surfaces probed by force spectroscopy”, M. Batchelor, D. Zhou, M.A. Cooper, C. Abell and T. Rayment Org. Biomol. Chem., 2010, 8, 1142-1148, DOI: 10.1039/b919347b



  1. “Bio-functionalized protein resistant oligo(ethylene glycol)-derived polymer brushes as selective immobilization and sensing platforms” J. Trmcic-Cvitas, E. Hasan, M. Ramstedt, X. Li, M.A. Cooper, C. Abell W.T.S. Huck and J.E. Gautrot, Biomacromolecules, 2009, 10 (10), 2885-2894, DOI: 10.1021/bm900706r
  2. “Signal transduction profiling using label-free biosensors”, M.A.Cooper, J. Recept. Signal. Transduct., 2009, 29 (3-4), 224-233, DOI:10.1186/1477-3155-8-3,
    DOI: 10.1080/10799890903047825
  3. “Resonant Acoustic Profiling for Diagnostics” M.A. Cooper SENSOR 2009 Proceedings, 2009, Vol. 1, 23-28, DOI: 10.5162/sensor09/v1/a1.1
  4. “Quantitative detection of Staphylococcal enterotoxin B by Resonant Acoustic Profiling”, M. Natesan, M.A. Cooper, J.P. Tran, V.R. Rivera, and M.A. Poli, Anal. Chem., 2009, 81 (10), 3896-3902, DOI: 10.1021/ac900086t


  1. “Resonant Acoustic Profiling for Biological Detection and Diagnostics” W. Chiu, C.J. Hammond, R. Hammond, L. Harding, E. Hawkins, X. Li, S. Moore, K. Sanders, A. Sleptsov, C. Zhou and M.A. Cooper, Proc. IEEE Intl. Freq. Control Symp., 2008, 350-355, DOI: 10.1109/FREQ.2008.4623018
  2. “Nanomechanical detection of antibiotic-mucopeptide binding in a model for superbug resistance”, J.W. Ndieyira, M. Watari, A.D. Barrera, D. Zhou, M. Vogtli, M. Batchelor, M.A. Cooper, T. Strunz, M.A. Horton, C. Abell, T. Rayment, G. Aeppli and R.A.McKendry, Nature Nanotechnol., 2008, 3 (11), 691-696, DOI: 10.1038/nnano.2008.275
  3. “A high sensitivity assay for the inflammatory market C-Reactive protein employing acoustic biosensing”, J.D. McBride and M.A. Cooper, J. Nanobiotechnol., 2008, 6 (5),
    DOI: 10.1186/1477-3155-6-5
  4. “Direct acoustic profiling of DNA hybridization using HSV viral sequences”, Y. Uludag, X. Li, H. Coleman, S. Efstathiou and M.A. Cooper, Analyst, 2008, 132, 52-57,
    DOI: 10.1039/b711850c
  5. “Single step biocompatible coating for sulfhydryl coupling of receptors via
    2-(pyridinyldithio)ethylcarbamoyl dextran”, X. Li, C. Abell, and M.A. Cooper, Colloid Interfac. Sci. B., 2008, 61, 113-117, DOI: 10.1016/j.colsurfb.2007.06.026


  1. “A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions”, M.A. Cooper and V.T. Singleton, J. Mol. Recognit., 2007, 20 (3), 154-184, DOI: 10.1002/jmr.826
  2. “Piezoelectric sensors based on molecular imprinted polymers for quantitative detection of low molecular weight analytes”, Y. Uludağ, S.A. Piletsky, A.P.F. Turner and M.A. Cooper, FEBS, 2007, 274, 5471-5480, DOI: 10.1111/j.1742-4658.2007.06079.x
  3. “Profiling of molecular interactions in real time using acoustic detection”, B. Godber, M. Frogley, M. Rehak, A. Sleptsov, K.S.J. Thompson, Y. Uludag, and M.A. Cooper, Biosens. Bioelectron., 2007, 22 (9-10), 2382-2386, DOI: 10.1016/j.bios.2006.10.019


  1. “Acoustic detection technology in the analysis of biomolecular interactions”, E. Hawkins, M.A. Cooper and I. Campbell, Innovat. Pharm. Technol., 2006, 21, 30-34
  2. “Non-optical screening platforms: the next wave in label-free screening?”, M.A. Cooper, Drug Discov. Today, 2006, 11 (23/24), 1068-1074, DOI: 10.1016/j.drudis.2006.10.001
  3. “Quantification of small molecule-receptor affinities and kinetics by acoustic profiling”, X. Li, K.S.J. Thompson, B. Godber, and M.A. Cooper, Assay Drug Dev. Technol., 2006, 4 (5), 565-573, DOI: 10.1089/adt.2006.4.565
  4. “Current biosensor technologies in drug discovery”, M.A. Cooper, Drug Discov. World, 2006, 7 (3), 68-82
  5. “Real-time label-free acoustic technology for rapid detection of E. coli 0157:H7” L. Huang and M.A.Cooper, Clin. Chem, 2006, 52 (11), 2148-2151, DOI: 10.1373/clinchem.2006.072652
  6. “Optical biosensors; where next and how soon?”, M.A. Cooper, Drug Discov. Today, 2006, 11 (23/24), 1061-1067, DOI: 10.1016/j.drudis.2006.10.003

top of page


  1. “Profiling molecular interactions using label-free acoustic screening”, M.A. Cooper and C.Whalen, Drug Discov. Today: Technologies., 2005, 2 (3), 241-245,
    DOI: 10.1016/j.ddtec.2005.08.014
  2. “Direct quantification of analyte concentration by Resonant Acoustic Profiling™ (RAP™)”, B. Godber, K.S.J. Thompson, M. Rehak, Y. Uludag, S. Kelling, A. Sleptsov, M. Frogley, K. Wiehler, C. Whalen and M.A. Cooper, Clin. Chem, 2005, 51 (10), 1962-1972,
    DOI: 10.1373/clinchem.2005.053249


  1. “The photodynamic therapy (PDT) anticancer activity of a range of porphyrin dimers and related compounds derived from hematoporphyrin”, C.J. Byrne, M.A. Cooper, P.A. Cowled, R.A.W. Johnstone, L. Mackenzie, L.V. Marshallsay, I.K. Morris, C.A. Muldoon, M.J.Raftery, S.S. Yin and A.D. Ward., Aust. J. Chem., 2004, 57, 1091-1102, DOI: 10.1071/CH04062
  2. “A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-қB and NFAT families”, M. de Lumley, D.J. Hart, M.A. Cooper, S. Symeonides and J.M. Blackburn, J. Mol. Biol, 2004, 339 (5), 1059-1075, DOI: 10.1016/j.jmb.2004.03.083
  3. “Formation of dihydroxyselenides from allylic alcohols and their conversion to -hydroxy epoxides via substitution of a phenylselenonyl group.”, M.A. Cooper and A.D. Ward, Tetrahedron, 2004, 60 (36), 7963-7972, DOI: 10.1016/j.tet.2004.05.084
  4. “Advances in membrane receptor screening and analysis”, M.A. Cooper, J. Mol. Recognit., 2004, 17 (4), 286-315, DOI: 10.1002/jmr.675
  5. “A novel method of resistance for influenza against a channel-blocking anti-viral drug”, P. Astrahan, I. Kass, M.A. Cooper and I. T. Arkin, Proteins: Structure, Function, and Bioinformatics. 2004, 55 (2), 251-257, DOI: 10.1002/prot.20018



  1. “Design, synthesis, conformational analysis and nucleic acid hybridisation properties of thymidyl pyrrolidine-amide oligonucleotide mimics (POM)”, D.T. Hickman, T.H.S. Tan, J. Morral, P.M. King, M.A. Cooper and J. Micklefield, Org. Biomol. Chem. 2003, 1 (19), 3277-3292, DOI: 10.1039/b306156f
  2. “Biosensor profiling of molecular interactions in pharmacology”, M.A. Cooper, Curr. Op. Pharmacology, 2003, 3, 557-562, DOI: 10.1016/j.coph.2003.05.003
  3. “Label-free screening of bio-molecular interactions”, M.A. Cooper, Anal. Bioanal. Chem., 2003, 377 (5), 834-842, DOI: 10.1007/s00216-003-2111-y
  4. “Biosensing using rupture event scanning (REVS)”, M.A. Cooper, Meas. Sci. Technol., 2003, 14, 1888-1893, DOI: 10.1088/0957-0233/14/11/006
  5. “G-Quadruplex-Specific Peptide-Hemicyanine Ligands by Partial Combinatorial Selection”, J.A. Schouten, S. Ladame, S.J. Mason, M.A. Cooper and S. Balasubramanian, J. Am. Chem. Soc., 2003, 125, 5594- 5595, DOI: 10.1021/ja029356w
  6. “Binding of an inhibitor of the p53/MDM2 interaction to MDM2”, S.J. Duncan, M A. Cooper and D.H. Williams, J. Chem. Soc. Chem. Commun., 2003, (3), 316-317, DOI: 10.1039/b211889k


  1. “Sensitive and direct detection using Rupture Event Scanning (REVS)” S. Kelling, M.A. Cooper, K. Stirrups, R. Karamanska, V.P. Ostanin, D. Klenerman, A. Slepstov, M. Rehak, F.N. Dultsev, T. Minson and C. Abell, Proc. IEEE Intl. Freq. Control Symp., 2002, 756-760,
    DOI: 10.1109/FREQ.2002.1075982
  2. “Crystal structure of 2-(R*)-phenylselenomethyl-3(R*)-hydroxypyrrolidine-1-tosylate, C18H21NO3SSe”, M.A. Cooper, A.D. Ward and E.R.T. Tiekink, Z.Krist., 2002, 217, 343-344
  3. “Crystal structure of 2-(1-phenylselenonyl-1-phenylethoxy)ethanol, C16H18O4Se”, M.A. Cooper, A.D. Ward and E.R.T. Tiekink, Z.Kristallogr., 2002, 217, 345-346
  4. “A Sensitve and Economical Method to Directly Detect Particles”, M.A. Cooper, V.P. Ostanin, D. Klenerman, A. Slepstov, R. Karamanska, F.N. Dultsev, K. Stirrups, S. Kelling, T. Minson and C. Abell, Sensors 2002, Proceedings of IEEE, 2002, 2, 1042-1045, DOI:10.1109/ICSENS.2002.1037256
  5. “Optical Biosensors in Drug Discovery”, M.A. Cooper, Nature Rev. Drug Discov., 2002, 1, 515-528, DOI: 10.1038/nrd838
  6. “Mechanism of the regulation of type IB phosphoinositide 3OH-kinase by G protein subunits”, S. Krugmann, M.A. Cooper, D.H. Williams, P.T. Hawkins, and L.R. Stephens, Biochem. J., 2002, 362 (3), 725-731, DOI: 10.1042/bj3620725

  7. "Label-free screening of molecular interactions using acoustic detection", M.A. Cooper, Drug Discovery Today, 2002, 7 (5), S5-S7, DOI: 10.1007/s00216-003-2111-y
  8. "Acoustic detection of pathogens using rupture event scanning (REVS)", M.A. Cooper, Directions in Science, 2002, 1, 1-2, DOI: 10.1100/tsw.2002.68
  9. "Identification of ARAP3, a Novel PI3K Effector Regulating Both Arf and Rho GTPases, by Selective Capture on Phosphoinositide Affinity Matrices", S. Krugmann, K.E. Anderson, S.H. Ridley, N. Risso, A. McGregor, J. Coadwell, K. Davidson, A. Eguinoa, C.D. Ellson, P. Lipp, M. Manifava, N. Ktistakis, G. Painter, J.W. Thuring, M.A. Cooper, Z.-Y. Lim, A.B. Holmes, S.K. Dove, R.H. Michell, A. Grewal, A. Nazarian, H. Erdjument-Bromage, P. Tempst, L.R. Stephens and P.T. Hawkins, Mol. Cell, 2002, 9 (1), 95-108,
    DOI: 10.1016/S1097-2765(02)00434-3
  10. "The orientation of the antibiotic peptide maculatin 1.1 in DMPG and DMPC lipid bilayers. Support for a pore-forming mechanism", C.S.B. Chia, J. Torres, M.A. Cooper, I.T. Arkin and J.H. Bowie, FEBS Lett., 2002, 512 (1-5), 47-51, DOI: 10.1016/S0014-5793(01)03313-0



  1. "FENS-1 and FERG-1 are FYVE domain-containing proteins with distinct functions in the endosomal and Golgi compartments", S.H. Ridley, N. Ktistakis, K. Davidson, K.E. Anderson, M. Manifava, C.D. Ellson, P. Lipp, M. Bootman, J. Coadwell, A. Nazarian, H. Erjumont-Bromage, P. Tempst, M.A. Cooper, J.W.J.F. Thuring, z.-y. Lim, A.B. Holmes, L.R. Stephens and P.T. Hawkins, J. Cell. Sci, 2001, 114, 3991-4000
  2. "The synthesis of N-benzoyl aziridines from -benzamidoalkyl phenyl selenides", V.R. Ward, M.A. Cooper and A. D. Ward, Phophorus Sulfur Silicon and the Related Elements, 2001, 172 (1), 195-201, DOI: 10.1080/10426500108046651
  3. "Kinetically selective binding of single stranded RNA over DNA by a pyrrolidine–amide oligonucleotide mimic (POM)", D.T. Hickman, P.M. King, J.M. Slater, M.A. Cooper, and J. Micklefield, Nucleosides, Nucleotides & Nucleic Acids, 2001, 20 (4), 1169-1172, DOI: 10.1081/NCN-100002512
  4. “Direct and sensitive detection of a human virus by rupture event scanning”, M.A. Cooper, F.N. Dultsev, T. Minson, V.P. Ostanin, C. Abell, and D. Klenerman, Nature Biotech., 2001, 19, 833-837, DOI: 10.1038/news010906-1
  5. "Phosphatidylinositol 3-phosphate regulates the neutrophil oxidase complex by binding to the PX domain of p40phox ", C.D. Ellson, S. Gobert-Gosse, K.E. Anderson, K. Davidson, H. Erdjument-Bromage, P. Tempst, J.W. Thuring, M.A. Cooper, Z.-Y. Lim, A.B. Holmes, P.R.J. Gaffney, J. Coadwell, E.R. Chilvers, P.T. Hawkins and L.R. Stephens, Nature Cell Biol., 2001, 3, 679-682, DOI: 10.1038/35083076
  6. "Synthesis of N-acylaziridines from -amido selenides", V.R Ward, M.A. Cooper and A.D. Ward, J. Chem. Soc., Perkin Trans.I, 2001, 944-945, DOI: 10.1039/b102468j
  7. “Chemical force microscopy with active enzymes”, M. Fiorini, R. McKendry, M.A. Cooper, T. Rayment, and C. Abell, Biophys J., 2001, 80, 2471-2476, DOI: 10.1016/S0006-3495(01)76215-7
  8. “A convenient method for the aromatic amino-Claisen rearrangement of N-(1,1-disubstituted-allyl)anilines”, M.A. Cooper, M.A. Lucas, J.M. Taylor, A.D. Ward and N.M. Williamson, Synthesis, 2001, 4, 621-625, DOI: 10.1055/s-2001-12349


  1. "Unusual RNA & DNA binding properties of a novel pyrrolidine–amide oligonucleotide mimic (POM)", D.T. Hickman, P.M. King, M.A. Cooper, J.M. Slater and J. Micklefield, J. Chem. Soc. Chem. Commun., 2000, 2251-2252, DOI: 10.1039/b006903p
  2. “Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers”, M.A. Cooper, M.T. Fiorini, C. Abell, and D.H. Williams, Biorg. Med. Chem, 2000, 8, 2609-2616, DOI: 10.1016/S0968-0896(00)00184-X
  3. "The reactions of N-substituted-2-(2-dimethylallyl)aniline compounds with phenylselanyl halides", M.A. Cooper, C. L. Francis, J. W. Holman, B. Kasum, T. Taverner, E. R. T. Tiekink, and A. D. Ward, Aust. J. Chem, 2000, 53, 123-129, DOI: 10.1071/CH99109
  4. "Kinetic analysis of high-mobility-group proteins HMG1 and HMGI/Y binding to cholesteroltagged DNA on a supported lipid monolayer", C.I. Webster, M.A. Cooper, L.C. Packman, D.H. Williams, and J.C. Gray, Nucleic Acids Res., 2000, 28 (7), 1618-1624,
    DOI: 10.1093/nar/28.7.1618
  5. "A vesicle capture sensor chip for kinetic analysis of binding to membrane-bound receptors ", M.A. Cooper, A. Hansson, S. Löfas, S. and D.H. Williams, Anal. Biochem., 2000, 277, 196-205, DOI: 10.1006/abio.1999.4389


  1. "Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium", M.A. Cooper, and D. H. Williams, Chem. Biol., 1999, 6, 891-899, DOI:10.1016/S1074-5521(00)80008-3
  2. "Kinetic analysis of an antibody-antigen interaction on a supported lipid monolayer", M.A. Cooper, and D.H. Williams, Anal. Biochem, 1999, 276, 36-47, DOI: 10.1006/abio.1999.4333
  3. "High affinity surface binding of a strongly dimerising vancomycin group antibiotic to a model of resistant bacteria", D.P. O'Brien, R.M.H. Entress, M.A. Cooper, S.W. O'Brien, A. Hopkinson, and D.H. Williams, J. Am. Chem. Soc., 1999, 121, 5259-5265, DOI: 10.1021/ja9839769
  4. "Synthesis of extended bacterial cell-wall precursor analogues for ligand binding studies with glycopeptide antibiotics", T. Staroske, J. Görlitzer, R.M.H. Entress, M.A. Cooper and D.H. Williams, J. Chem. Soc., Perkin Trans. 1, 1999, 1105-1107, DOI: 10.1039/A809427F
  5. "The salt dependence of DNA recognition by NF-[kappa]B p50: a detailed kinetic analysis of the effects on affinity and specificity", D.J. Hart, R.E. Speight, M.A. Cooper, J.D. Sutherland, J.M. Blackburn, Nucleic Acids Res., 1999, 27 (4), 1063-1069, DOI: 10.1093/nar/27.4.1063


  1. "Surface Plasmon Resonance Analysis at a Supported Lipid Monolayer", M.A. Cooper, A.C. Try, J. Carroll, D.J. Ellar, D.H. Williams, Biophys. Biochim, Acta, 1998, 1373, 101-111, DOI: 10.1016/S0005-2736(98)00091-1
  2. "Bacillus thuringiensis Cry1Ac toxin interaction with Manduca sexta aminopeptidase N in a model membrane environment", M.A. Cooper, J. Carroll, E.R. Travis, D.H. Williams and D.J. Ellar, Biochem. J., 1998, 333, 677-683, DOI: 10.1042/bj33306779
  3. "19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces which mimic VanA and VanB resistance", R.M.H. Entress, R.J. Dancer, D.P. O'Brien, A.C. Try, M.A. Cooper and D.H. Williams, Chem. Biol., 1998, 5, 329-337, DOI: 10.1016/S1074-5521(98)90171-5



  1. "The roles of dimerisation and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria", G. J. Sharman, A.C. Try, R.J. Dancer, Y.R. Cho, T. Staroske, B. Bardsley, A.J. Maguire, M.A. Cooper, D.P. O'Brien and D.H. Williams, J. Am. Chem. Soc, 1997, 119, 12041-12047, DOI: 10.1021/ja964477f
  2. "Surface plasmon resonance analysis of glycopeptide antibiotic activity at a model membrane surface", M.A. Cooper, D.H. Williams, and Y.R. Cho, J. Chem. Soc. Chem. Commun., 1997, 17, 1625-1626, DOI: 10.1039/a703943c
  3. “Synthesis and substitution reactions of N-protected-2-(phenylselenonylmethyl)-pyrrolidines”, M.A. Cooper and A. D. Ward, Aust. J. Chem., 1997, 50, 181-187, DOI: 10.1071/C96148



  1. "Crystal structure of ethyl 2-(phenylselenonylmethyl)pyrrolidine carboxylate", M.A. Cooper, E. R. T. Tiekink and A. D. Ward, Z.Krist., 1996, 211, 751-752,
    DOI: 10.1524/zkri.1996.211.10.751



  1. "Hydroxyselenation of allylic alcohols", M.A. Cooper and A. D. Ward, Tetrahedron Lett., 1995, 36 (13), 2327-2330, DOI: 10.1016/0040-4039(95)00247-A
  2. "Unusually stable hydrates of N-substituted 3-hydroxy-2 (phenylselenenyl)methylpiperidine derivatives. Where is the water? An NMR study", M.A. Cooper, S. M. Pyke, and A. D. Ward, Bull. Magn. Reson. 1995, 17 (1-4), 244-245



  1. "Selenium induced stereo-selective cyclization of N-substituted 4-hydroxy-5-hexenylamines", M.A. Cooper and A. D. Ward, Tetrahedron Lett., 1994, 35, 5065-5068, DOI: 10.1016/S0040-4039(00)73321-1



  1. "Selenium induced stereo-selective cyclizations of N-protected 3-hydroxy-4-pentenylamines", M.A. Cooper and A. D. Ward, Tetrahedron Lett., 1992, 33, 5999-6002, DOI: 10.1016/S0040-4039(00)61110-3


10 patent families with 19 international filings.

top of page